col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: The Lancet
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―13 Disrupted care in Papua New Guinea: the harms of COVID-19 Chris McCall
2 [GO] 2022―Jan―13 Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin Rajalakshmi Valaiyapathi, Meng-San Wu, Alastair McGregor
3 [GO] 2021―Dec―31 COVID-19 ARDS: getting ventilation right - Authors' reply Ryan P Barbaro, Graeme MacLaren, Justyna Swol, Arthur S Slutsky, Daniel Brodie
4 [GO] 2021―Dec―31 COVID-19 ARDS: getting ventilation right Xosé L Pérez-Fernández, Joan Sabater-Riera, MariPaz Fuset-Cabanes
5 [GO] 2021―Dec―31 Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management Joseph Heskin, Scott J C Pallett, Nabeela Mughal, Gary W Davies, Luke S P Moore, Michael Rayment, Rachael Jones
6 [GO] 2021―Dec―24 Mandatory COVID-19 vaccination and human rights Jeff King, Octávio Luiz Motta Ferraz, Andrew Jones
7 [GO] 2021―Dec―24 Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial Scott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, Bruce Smith, Pedro E Cahn, Guillermo M Ruiz-Palacios, et al. (+42)
8 [GO] 2021―Dec―24 Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine Richard B Kennedy
9 [GO] 2021―Dec―22 LGBTQ youth mental health during COVID-19: unmet needs in public health and policy Cameron K Ormiston, Faustine Williams
10 [GO] 2021―Dec―20 Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil Srinivasa Vittal Katikireddi, Thiago Cerqueira-Silva, Eleftheria Vasileiou, Chris Robertson, Sarah Amele, Jiafeng Pan, et al. (+18)
11 [GO] 2021―Dec―20 Diagnostics for COVID-19: moving from pandemic response to control Rosanna W Peeling, David L Heymann, Yik-Ying Teo, Patricia J Garcia
12 [GO] 2021―Dec―20 Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum Wanwisa Dejnirattisai, Robert H Shaw, Piyada Supasa, Chang Liu, Arabella SV Stuart, Andrew J Pollard, et al. (+8)
13 [GO] 2021―Dec―20 Managing waning vaccine protection against SARS-CoV-2 variants Kathy Leung, Joseph T Wu
14 [GO] 2021―Dec―16 Projecting COVID-19 disruption to elective surgery COVIDSurg Collaborative
15 [GO] 2021―Dec―16 COVID-19 vaccine strategies must focus on severe disease and global equity Peter B McIntyre, Rakesh Aggarwal, Ilesh Jani, Jaleela Jawad, Sonali Kochhar, Noni MacDonald, et al. (+9)
16 [GO] 2021―Dec―16 COVID-19: where do we go from here? The Lancet
17 [GO] 2021―Dec―15 Anticoagulation in COVID-19 Charlotte A Bradbury, Zoe McQuilten
18 [GO] 2021―Dec―15 Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, Valéria Cristina Resende Aguiar, Alex C Spyropoulos, Caroline Candida Carvalho de Oliveira, et al. (+38)
19 [GO] 2021―Dec―11 Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability Suerie Moon, Jana Armstrong, Brian Hutler, Ross Upshur, Rachel Katz, Caesar Atuire, et al. (+12)
20 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 Brian Lipworth, Rory Chan, Rasads Misirovs
21 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 Ivan Berezowski, Jigar Patel, Mariame Shaw, Ali Pourmand
22 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 - Authors' reply F D Richard Hobbs, Ly-Mee Yu, Benjamin R Saville, Mona Bafadhel, Christopher C Butler
23 [GO] 2021―Dec―08 Preparing for future pandemics in the Eastern Mediterranean region Wasiq Khan, Abdinasir Abubakar, Richard J Brennan, Farida Al Hosani, Thoraya Obaid, Anders Nordstrom, Peter Friberg
24 [GO] 2021―Dec―06 Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19 Christopher D Richardson
25 [GO] 2021―Dec―06 Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial Arabella S V Stuart, Robert H Shaw, Xinxue Liu, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+37)
26 [GO] 2021―Dec―03 Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic Salim S Abdool Karim, Quarraisha Abdool Karim
27 [GO] 2021―Dec―02 Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial Alasdair P S Munro, Leila Janani, Victoria Cornelius, Parvinder K Aley, Gavin Babbage, David Baxter, et al. (+301)
28 [GO] 2021―Nov―26 Evaluation of the impact of tiered restrictions introduced in England during October and December, 2020, on COVID-19 cases: a synthetic control study Xingna Zhang, Gwilym Owen, Mark Green, Iain Buchan, Ben Barr
29 [GO] 2021―Nov―26 COVID-19 and prepandemic all-cause inequalities in disability-adjusted life-years due to multiple deprivation: a Scottish Burden of Disease study Grant M A Wyper, Eilidh Fletcher, Ian Grant, Oliver Harding, Maria Teresa de Haro Moro, Diane L Stockton, Gerry McCartney
30 [GO] 2021―Nov―26 “It's been up and down”-perspectives on living through COVID-19 for individuals who experience homelessness: a qualitative study Emma A Adams, Jeff Parker, Tony Jablonski, Joanne Kennedy, Desmond Hunter, Fiona Tasker, et al. (+9)
31 [GO] 2021―Nov―26 SARS-CoV-2 testing, infections, and hospital admissions with COVID-19 in children and young people in Scotland: a birth cohort study Graziella Favarato, Linda Wijlaars, Tom Clemens, Steve Cunningham, Bianca De Stavola, Chris Dibben, et al. (+7)
32 [GO] 2021―Nov―26 The severity of COVID-19 infection in patients with anorexia nervosa: an observational study Michael J Taylor, Uju Okereke, Robert Wilson, Anthony Winston
33 [GO] 2021―Nov―26 An exploration of the uptake of asymptomatic COVID-19 lateral flow testing in Birmingham, UK: cross-sectional survey and qualitative analysis Jonathan Mathers, Christopher Poyner, Dean Thompson, Gavin Rudge, Ruth Pritchett
34 [GO] 2021―Nov―26 Resilience of elective cancer surgery systems during COVID-19 lockdowns: an international, multicentre, prospective cohort study
35 [GO] 2021―Nov―26 Attitudes towards COVID-19 mitigation measures implemented at St Mark's Bowel Cancer Screening Centre: a cross-sectional analysis of survey data from an ethnically diverse region in London Andrew Prentice, Ghalial Kayal, Sarah Marshall, Christian von Wagner, Robert S Kerrison
36 [GO] 2021―Nov―26 Measuring the impact of COVID-19 on sexual and reproductive health in the UK: web-panel surveys with qualitative follow-up Nigel Field, Emily Dema, Andrew J Copas, Soazig Clifton, Anne Conolly, Margaret Blake, et al. (+8)
37 [GO] 2021―Nov―26 Individuals with lived experience of homelessness and their COVID-19 outcomes in Wales: a data linkage study Jiao Song, Chris Moreno-Stokoe, Charlotte Grey, Alisha R Davies
38 [GO] 2021―Nov―26 Health protocol compliance integrated monitoring system to inform public health actions during the COVID-19 pandemic in Indonesia Dewi Nur Aisyah, Thifal Kiasatina, Gayatri I Gusti, Wiku Adisasmito, Logan Manikam, Zisis Kozlakidis
39 [GO] 2021―Nov―26 Population birth outcomes and experiences of expectant mothers during the COVID-19 pandemic in Wales: a mixed methods study Hope Jones, Mike Seaborne, Laura Cowley, David Odd, Shantini Paranjothy, Ashley Akbari, Sinead Brophy
40 [GO] 2021―Nov―26 Community-led action in response to the COVID-19 pandemic in Wales: a national, cross-sectional survey Charlotte N B Grey, Lucia Homolova, Alisha Davies
41 [GO] 2021―Nov―26 Impact of the COVID-19 pandemic on health-care usage and mental health of clinically extremely vulnerable individuals in Wales: a population-scale data linkage study Alisha Davies, Jiao Song, Ashley Akbari, Laura Bentley, Bethan Carter, Lynsey Cross, et al. (+6)
42 [GO] 2021―Nov―26 Impact of the COVID-19 pandemic on psychotropic medication uptake in Northern Ireland: a population-wide trend analysis Lisa Kent, Dermot O'Reilly, Aideen Maguire
43 [GO] 2021―Nov―26 Effects of the COVID-19 pandemic on the mental health of shielded children and children living in shielded households in Wales: a data linkage study Laura Cowley, Jiao Song, Alisha Davies
44 [GO] 2021―Nov―26 Estimating the direct and indirect risks of becoming food insecure during the COVID-19 pandemic: a cross-sectional analysis using UK cohort data Susanna Mills, Viviana Albani, Heather Brown
45 [GO] 2021―Nov―26 Understanding risk and protective factors to UK railway workers' mental wellbeing during the COVID-19 pandemic: a cross-sectional survey Nicola Cogan, Megan McGibbon, Amy Gardener, Liza Morton
46 [GO] 2021―Nov―26 The importance of adaptive coping, peer support, psychological input, team resilience, and supportive management among fire and rescue service workers in maintaining wellbeing throughout the COVID-19 pandemic: a cross-sectional survey Nicola Cogan, Amy MacDonald
47 [GO] 2021―Nov―26 Variations in the incidence of common mental disorder symptoms in the general population throughout the COVID-19 pandemic: a longitudinal cohort study Rob Saunders, Joshua Eusty Jonathan Buckman, Peter Fonagy, Stephen Pilling, Feifei Bu, Daisy Fancourt
48 [GO] 2021―Nov―26 The effect of school and peer connectedness on adolescent mental health outcomes during the COVID-19 pandemic: a longitudinal panel survey Emily Widnall, Lizzy Winstone, Ruth Plackett, Emma Adams, Claire Haworth, Becky Mars, Judi Kidger
49 [GO] 2021―Nov―26 Exploring the role of people providing informal support to survivors of domestic abuse during the COVID-19 pandemic: a qualitative study Alison Gregory, Emma Williamson
50 [GO] 2021―Nov―26 Community-led support in South Wales in response to the COVID-19 pandemic: a qualitative study with a systems-lens approach Lucia Homolova, Charlotte N B Grey, Alisha Davies
51 [GO] 2021―Nov―26 Reduced ability to engage in social and physical activity and mental health of older adults during the COVID-19 pandemic: longitudinal analysis from the Canadian Longitudinal Study on Aging Theodore D Cosco, Andrew Wister, Indira Riadi, Lucy Kervin, John Best, Parminder Raina
52 [GO] 2021―Nov―26 Scientific advice and COVID-19 policy making in the UK: an oral history study Paul Atkinson, Hayley Mableson, Sally Sheard
53 [GO] 2021―Nov―26 COVID-19 recovery from the community perspective in Middlesbrough: a coproduction cross-sectional study Andrew Divers, Catherine Parker, Parisa Diba, Clifford Johnson, Dorothy Newbury-Birch
54 [GO] 2021―Nov―26 Placing health equity at the heart of the COVID-19 recovery: data analysis from the first Welsh Health Equity Status Report initiative James Allen, Andrew Cotter-Roberts, Anna Stielke, Rajendra Kadel, Benjamin Bainham, Kathryn Ashton, et al. (+2)
55 [GO] 2021―Nov―26 Increased COVID-19 related mortality rate for patients with rare diseases: a retrospective cohort study with data from Genomics England Huayu Zhang, Johan Thygesen, Honghan Wu
56 [GO] 2021―Nov―26 Design and implementation of a university-based COVID-19 testing programme: an observational study Claire Blackmore, Gareth W Hall, Rebecca C Allsopp, Anna L Hansell, Caroline M Cowley, Ruth C Barber, et al. (+5)
57 [GO] 2021―Nov―26 Challenges of self-isolation among contacts of cases of COVID-19: a national telephone survey in Wales Kate R Isherwood, Richard G Kyle, Benjamin J Gray, Alisha R Davies
58 [GO] 2021―Nov―26 Community-academic partnerships addressing local health inequalities during COVID-19: a qualitative evaluation Meerat Kaur, Bethany Golding, Arti Maini, Sonia Kumar
59 [GO] 2021―Nov―26 A pilot study of PCR community mass testing for COVID-19: who attends and who tests positive? Kate Levin, Beatrix von Wissmann
60 [GO] 2021―Nov―25 COVID-19 and myocardial infarction Daniel Caldeira, Fausto J Pinto
61 [GO] 2021―Nov―25 COVID-19 and myocardial infarction - Authors' reply Ioannis Katsoularis, Osvaldo Fonseca-Rodríguez, Paddy Farrington, Krister Lindmark, Anne-Marie Fors Connolly
62 [GO] 2021―Nov―25 A reproductive justice response to HIV/AIDS and COVID-19 Jallicia Jolly
63 [GO] 2021―Nov―25 Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply N Hélène Sawadogo, Hamidou Sanou, Jeremy A Greene, Vincent Duclos
64 [GO] 2021―Nov―25 Beyond COVID-19: scaling up and sustaining mobile health in Africa Yap Boum
65 [GO] 2021―Nov―25 Countries prepare for pandemic treaty decision John Zarocostas
66 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 Chengliang Yang, Hedi Zhao, Scott J Tebbutt
67 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 Yan-Jie Zhao, Wei Bai, Zhaohui Su, Chee H Ng, Yu-Tao Xiang
68 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 - Authors' reply Lixue Huang, Xiaoying Gu, Bin Cao
69 [GO] 2021―Nov―18 Legal challenges threaten Biden's COVID-19 vaccine rule Susan Jaffe
70 [GO] 2021―Nov―18 COVID-19: stigmatising the unvaccinated is not justified Günter Kampf
71 [GO] 2021―Nov―17 Studying the coagulopathy of COVID-19 Alex C Spyropoulos, Marc P Bonaca
72 [GO] 2021―Nov―17 Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6209)
73 [GO] 2021―Nov―15 Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA Saad B Omer, Regina M Benjamin, Noel T Brewer, Alison M Buttenheim, Timothy Callaghan, Arthur Caplan, et al. (+16)
74 [GO] 2021―Nov―11 Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 Jing-Xin Li, Feng-Cai Zhu
75 [GO] 2021―Nov―11 Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial Rajeka Lazarus, Sarah Baos, Heike Cappel-Porter, Andrew Carson-Stevens, Madeleine Clout, Lucy Culliford, et al. (+178)
76 [GO] 2021―Nov―11 Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial Raches Ella, Siddarth Reddy, William Blackwelder, Varsha Potdar, Pragya Yadav, Vamshi Sarangi, et al. (+23)
77 [GO] 2021―Nov―11 Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? Sue Pavord, Marie Scully, Will Lester, Mike Makris, Beverley J Hunt
78 [GO] 2021―Nov―11 Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors’ reply Prakash Bhuyan, Jennie Medin, Hugo Gomes da Silva, Madhavi Yadavalli, Magnus Nord
79 [GO] 2021―Nov―08 How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic Sudhvir Singh, Christine McNab, Rose McKeon Olson, Nellie Bristol, Cody Nolan, Elin Bergstrøm, et al. (+11)
80 [GO] 2021―Nov―04 Health experts welcome Brazil COVID-19 inquiry findings Lise Alves
81 [GO] 2021―Nov―03 Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data Lucy A McNamara, Ryan E Wiegand, Rachel M Burke, Andrea J Sharma, Michael Sheppard, Jennifer Adjemian, et al. (+16)
82 [GO] 2021―Nov―03 The value of vaccine programme impact monitoring during the COVID-19 pandemic Justin R Ortiz, Kathleen M Neuzil
83 [GO] 2021―Oct―29 Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study Noam Barda, Noa Dagan, Cyrille Cohen, Miguel A Hernán, Marc Lipsitch, Isaac S Kohane, et al. (+2)
84 [GO] 2021―Oct―28 Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland Zoe Grange, Audrey Buelo, Christopher Sullivan, Emily Moore, Utkarsh Agrawal, Khaled Boukhari, et al. (+6)
85 [GO] 2021―Oct―28 Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study Raphael Sonabend, Lilith K Whittles, Natsuko Imai, Pablo N Perez-Guzman, Edward S Knock, Thomas Rawson, et al. (+11)
86 [GO] 2021―Oct―28 Unclear conclusions on SARS-CoV-2 elimination versus mitigation Christian Gold
87 [GO] 2021―Oct―28 Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply Miquel Oliu-Barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, Samantha Vanderslott
88 [GO] 2021―Oct―28 Nowcasting towards sustainable SARS-CoV-2 endemicity Gabriel M Leung
89 [GO] 2021―Oct―22 COVID-19 and the rebiologisation of racial difference Wingel Xue, Alexandre White
90 [GO] 2021―Oct―22 Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination Kushalinii Hillson, Sue Costa Clemens, Shabir A Madhi, Merryn Voysey, Andrew J Pollard, Angela M Minassian
91 [GO] 2021―Oct―15 Developing COVID-19 vaccine policy in increments Michael S Saag
92 [GO] 2021―Oct―09 Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns Maxime Taquet, Emily A Holmes, Paul J Harrison
93 [GO] 2021―Oct―09 Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic Damian F Santomauro, Ana M Mantilla Herrera, Jamileh Shadid, Peng Zheng, Charlie Ashbaugh, David M Pigott, et al. (+61)
94 [GO] 2021―Oct―08 Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, John H Alexander, Otavio Berwanger
95 [GO] 2021―Oct―08 Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
96 [GO] 2021―Oct―08 The path to global equity in mental health care in the context of COVID-19 Lola Kola, Brandon A Kohrt, Bibhav Acharya, Byamah B Mutamba, Christian Kieling, Manasi Kumar, et al. (+3)
97 [GO] 2021―Oct―07 Can COVID-19 help accelerate and transform the diagnostics agenda? Sabine Kleinert, Richard Horton
98 [GO] 2021―Oct―05 Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Sara Y Tartof, Jeff M Slezak, Heidi Fischer, Vennis Hong, Bradley K Ackerson, Omesh N Ranasinghe, et al. (+9)
99 [GO] 2021―Oct―05 Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore Chuan De Foo, Karen A Grépin, Alex R Cook, Li Yang Hsu, Michael Bartos, Sudhvir Singh, et al. (+4)
100 [GO] 2021―Oct―05 Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients Maria Prendecki, Tina Thomson, Candice L Clarke, Paul Martin, Sarah Gleeson, Rute Cardoso De Aguiar, et al. (+11)
101 [GO] 2021―Sep―30 Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry Ryan P Barbaro, Graeme MacLaren, Philip S Boonstra, Alain Combes, Cara Agerstrand, Gail Annich, et al. (+10)
102 [GO] 2021―Sep―30 COVID-19 research in LMICs Ivan Sisa, Marco Fornasini, Enrique Teran
103 [GO] 2021―Sep―30 COVID-19 research in LMICs - Authors' reply Irene Torres, Barbara Profeta, Cristiani Vieira Machado, Osvaldo Artaza, Daniel Lopez-Cevallos, JaHyun Kang
104 [GO] 2021―Sep―29 World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease Fausto J Pinto, Daniel Piñeiro, Amitava Banerjee, Pablo Perel, Borjana Pervan, Jean-Luc Eiselé
105 [GO] 2021―Sep―29 ECMO in COVID-19: do not blame the tool Alain Vuylsteke
106 [GO] 2021―Sep―24 Functioning of the International Health Regulations during the COVID-19 pandemic Preben Aavitsland, Ximena Aguilera, Seif Salem Al-Abri, Vincent Amani, Carmen C Aramburu, Thouraya A Attia, et al. (+13)
107 [GO] 2021―Sep―23 Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050 Angela E Micah, Ian E Cogswell, Brandon Cunningham, Satoshi Ezoe, Anton C Harle, Emilie R Maddison, et al. (+407)
108 [GO] 2021―Sep―23 COVID-19: learning as an interdependent world The Lancet
109 [GO] 2021―Sep―22 The long-term impact of COVID-19 on development assistance for health is still uncertain Osondu Ogbuoji, Wenhui Mao, Genevieve Aryeetey
110 [GO] 2021―Sep―17 An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 Jacques van Helden, Colin D Butler, Guillaume Achaz, Bruno Canard, Didier Casane, Jean-Michel Claverie, et al. (+10)
111 [GO] 2021―Sep―17 An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply Gerald T Keusch, Sai Kit Lam, John S Mackenzie, Linda Saif, Michael Turner
112 [GO] 2021―Sep―17 SARS-CoV-2's origin should be investigated worldwide for pandemic prevention Zhiqiang Wu, Qi Jin, Guizhen Wu, Jian Lu, Mingkun Li, Deyin Guo, et al. (+9)
113 [GO] 2021―Sep―14 Considerations in boosting COVID-19 vaccine immune responses Philip R Krause, Thomas R Fleming, Richard Peto, Ira M Longini, J Peter Figueroa, Jonathan A C Sterne, et al. (+12)
114 [GO] 2021―Sep―14 Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial Bernadette C Young, David W Eyre, Saroj Kendrick, Chris White, Sylvester Smith, George Beveridge, et al. (+25)
115 [GO] 2021―Sep―10 A new strategy for health and sustainable development in the light of the COVID-19 pandemic Mario Monti, Aleksandra Torbica, Elias Mossialos, Martin McKee
116 [GO] 2021―Sep―02 The long road ahead for COVID-19 vaccination in Africa Sara Jerving
117 [GO] 2021―Sep―02 The race to make a COVID-19 vaccine Sarah Boseley
118 [GO] 2021―Sep―01 Global youth advocating for COVID-19 vaccines for all Neema Kaseje, David Walcott
119 [GO] 2021―Sep―01 Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, Jeremy Aboagye, Parvinder K Aley, Brian Angus, et al. (+181)
120 [GO] 2021―Sep―01 Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine Elizabeth T Rogawski McQuade, Alexander Breskin
121 [GO] 2021―Aug―26 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Lixue Huang, Qun Yao, Xiaoying Gu, Qiongya Wang, Lili Ren, Yeming Wang, et al. (+19)
122 [GO] 2021―Aug―24 Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic Arghavan Salles, Reshma Jagsi
123 [GO] 2021―Aug―17 SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination Georg MN Behrens, Anne Cossmann, Metodi V Stankov, Inga Nehlmeier, Amy Kempf, Markus Hoffmann, Stefan Pöhlmann
124 [GO] 2021―Aug―13 Tackling Latin America's COVID-19 emergency requires greater solidarity Carissa F Etienne
125 [GO] 2021―Aug―13 Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave Jonathan M Read, Chris A Green, Ewen M Harrison, Annemarie B Docherty, Sebastian Funk, Janet Harrison, et al. (+8)
126 [GO] 2021―Aug―13 Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients Edward J Carr, Mary Wu, Ruth Harvey, Emma C Wall, Gavin Kelly, Saira Hussain, et al. (+78)
127 [GO] 2021―Aug―12 SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity Erkan Kalafat, Laura A Magee, Peter von Dadelszen, Pat O’Brien, Asma Khalil
128 [GO] 2021―Aug―10 The use of inhaled corticosteroids in early-stage COVID-19 Dee Mangin, Michelle Howard
129 [GO] 2021―Aug―10 Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Ly-Mee Yu, Mona Bafadhel, Jienchi Dorward, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, et al. (+46)
130 [GO] 2021―Aug―10 Serial intervals in SARS-CoV-2 B.1.617.2 variant cases Rachael Pung, Tze Minn Mak, Adam J Kucharski, Vernon J Lee
131 [GO] 2021―Aug―09 Towards a European strategy to address the COVID-19 pandemic Viola Priesemann, Rudi Balling, Simon Bauer, Philippe Beutels, André Calero Valdez, Sarah Cuschieri, et al. (+22)
132 [GO] 2021―Aug―06 Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study Richard J Perry, Arina Tamborska, Bhagteshwar Singh, Brian Craven, Richard Marigold, Peter Arthur-Farraj, et al. (+70)
133 [GO] 2021―Aug―06 Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+82)
134 [GO] 2021―Aug―06 Optimising SARS-CoV-2 vaccination schedules Cristobal Belda-Iniesta
135 [GO] 2021―Aug―05 COVID-19, online shaming, and health-care professionals Luna Dolezal, Arthur Rose, Fred Cooper
136 [GO] 2021―Aug―05 Critically ill COVID-19 patients in Africa: it is time for quality registry data Luigi Pisani, Wangari Waweru-Siika, Cornelius Sendagire, Abi Beane, Rashan Haniffa
137 [GO] 2021―Aug―05 Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply Bruce M Biccard, David Thomson, Malcolm Miller, Elliott H Taylor, P Dean Gopalan
138 [GO] 2021―Aug―04 Mucormycosis after COVID-19 in a patient with diabetes Khushboo Chauhan, Deepak Soni, Deepayan Sarkar, Tadepalli Karuna, Bhavana Sharma, Sarman Singh, Samendra Karkhur
139 [GO] 2021―Jul―30 COVID-19 vaccines for children in LMICs: another equity issue Beate Kampmann, Uduak Okomo
140 [GO] 2021―Jul―29 Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study Ioannis Katsoularis, Osvaldo Fonseca-Rodríguez, Paddy Farrington, Krister Lindmark, Anne-Marie Fors Connolly
141 [GO] 2021―Jul―29 What is the association of COVID-19 with heart attacks and strokes? Marion Mafham, Colin Baigent
142 [GO] 2021―Jul―29 Ethnic disparities in COVID-19: increased risk of infection or severe disease? Daniel Pan, Christopher A Martin, Joshua Nazareth, Clareece R Nevill, Jatinder S Minhas, Pip Divall, et al. (+5)
143 [GO] 2021―Jul―29 Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply Rohini Mathur, Christopher T Rentsch, Caroline E Morton, Rosalind M Eggo, Krishnan Bhaskaran, Laurie Tomlinsonn, et al. (+2)
144 [GO] 2021―Jul―29 Should global financing be the main priority for pandemic preparedness? Carel IJsselmuiden, Francine Ntoumi, James V Lavery, Jaime Montoya, Salim Abdool Karim, Kirsty Kaiser
145 [GO] 2021―Jul―29 Should global financing be the main priority for pandemic preparedness? - Authors' reply Nicole Lurie, Gerald T Keusch, Victor J Dzau
146 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? Avidan U Neumann, Mehmet Goekkaya, Karim Dorgham, Claudia Traidl-Hoffmann, Guy Gorochov
147 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? Chengliang Yang, Hedi Zhao
148 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply Peter Horby, Natalie Staplin, Richard Haynes, Martin Landray
149 [GO] 2021―Jul―21 Answering the call to support youth orphaned by COVID-19 Rachel A Kentor, Amanda L Thompson
150 [GO] 2021―Jul―21 Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond Alejandra Jáuregui, Estelle Victoria Lambert, Jenna Panter, Clover Moore, Deborah Salvo
151 [GO] 2021―Jul―21 Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study Susan D Hillis, H Juliette T Unwin, Yu Chen, Lucie Cluver, Lorraine Sherr, Philip S Goldman, et al. (+10)
152 [GO] 2021―Jul―20 Will the COVID-19 crisis catalyse universal health reforms? Lucinda Hiam, Robert Yates
153 [GO] 2021―Jul―20 COVID-19: the turning point for gender equality Senait Fisseha, Gita Sen, Tedros Adhanom Ghebreyesus, Winnie Byanyima, Debora Diniz, Henrietta H Fore, et al. (+11)
154 [GO] 2021―Jul―17 In-hospital complications associated with COVID-19 Xiaoying Gu, Bin Cao
155 [GO] 2021―Jul―17 COVID-19 in Africa: a lesson in solidarity The Lancet
156 [GO] 2021―Jul―17 Disruptions to childhood immunisation due to the COVID-19 pandemic Kaja Abbas, Vittal Mogasale
157 [GO] 2021―Jul―17 Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study Kate Causey, Nancy Fullman, Reed J D Sorensen, Natalie C Galles, Peng Zheng, Aleksandr Aravkin, et al. (+12)
158 [GO] 2021―Jul―17 Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study Thomas M Drake, Aya M Riad, Cameron J Fairfield, Conor Egan, Stephen R Knight, Riinu Pius, et al. (+397)
159 [GO] 2021―Jul―17 COVID-19: counting migrants in Sally Hargreaves, Sally E Hayward, Teymur Noori, Martin McKee, Bernadette Kumar
160 [GO] 2021―Jul―08 COVID-19 in Latin America-emergency and opportunity The Lancet
161 [GO] 2021―Jul―08 Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region Khuloud Alsaba
162 [GO] 2021―Jul―08 Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply Pierre Nabeth, Mahmoud Hassan, Keyrellous Adib, Abdinasir Abubakar, Richard Brennan
163 [GO] 2021―Jul―08 WHO COVID-19 therapeutic guidelines Bram Rochwerg, Thomas Agoritsas, Janet Diaz, Lisa Askie
164 [GO] 2021―Jul―08 WHO COVID-19 therapeutic guidelines - Authors' reply Nicholas J White, Nathalie Strub-Wourgaft, Abul Faiz, Philippe J Guerin
165 [GO] 2021―Jul―08 Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Mine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, Hatice Rahmet Güner, Alpay Azap, Sıla Akhan, et al. (+70)
166 [GO] 2021―Jul―06 7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics Thomas R Frieden, Christopher T Lee, Aaron F Bochner, Marine Buissonnière, Amanda McClelland
167 [GO] 2021―Jul―05 Science, not speculation, is essential to determine how SARS-CoV-2 reached humans Charles H Calisher, Dennis Carroll, Rita Colwell, Ronald B Corley, Peter Daszak, Christian Drosten, et al. (+18)
168 [GO] 2021―Jul―01 Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis Kirsten R Palmer, Michael Tanner, Miranda Davies-Tuck, Andrea Rindt, Kerrie Papacostas, Michelle L Giles, et al. (+9)
169 [GO] 2021―Jul―01 Sparks through the stubble: dying in a pandemic Rachel Clarke
170 [GO] 2021―Jul―01 Learning from crisis: building resilient systems to combat future pandemics Ilona Kickbusch, Gabriel M Leung, Robin J Shattock
171 [GO] 2021―Jun―28 AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, et al. (+18)
172 [GO] 2021―Jun―25 Heterologous vaccine regimens against COVID-19 Talita Duarte-Salles, Daniel Prieto-Alhambra
173 [GO] 2021―Jun―25 What constitutes success in the roll-out of COVID-19 vaccines? Maxwell J Smith
174 [GO] 2021―Jun―25 Pandemic response requires early and robust verification Susanna Lehtimaki, Pascale Allotey, Nina Schwalbe
175 [GO] 2021―Jun―25 More social discontent than pandemic-related risk perception in Colombia Alvaro J Idrovo
176 [GO] 2021―Jun―24 India's pain: beyond COVID-19 case numbers and mortality rates Rohini Dutta, Tarinee Kucchal
177 [GO] 2021―Jun―24 Can India's COVID-19 emergency be fixed without politics? Kunal Saha
178 [GO] 2021―Jun―24 India's COVID-19 emergency: overarching conclusions belie facts Dhavendra Kumar, Madhukar Mittal
179 [GO] 2021―Jun―24 India's COVID-19 response: science first Nita Radhakrishnan, Devendra Kumar Gupta
180 [GO] 2021―Jun―24 The complex causes of India's 2021 COVID-19 surge Aayush Visaria, Tina Dharamdasani
181 [GO] 2021―Jun―21 Addendum: competing interests and the origins of SARS-CoV-2 Editors of The Lancet
182 [GO] 2021―Jun―18 Five priorities for universal COVID-19 vaccination Adrien Abecassis
183 [GO] 2021―Jun―17 Protecting refugees during the COVID-19 pandemic The Lancet
184 [GO] 2021―Jun―14 SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness Aziz Sheikh, Jim McMenamin, Bob Taylor, Chris Robertson
185 [GO] 2021―Jun―11 SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban Katharina Guetl, Thomas Gary, Reinhard B Raggam, Johannes Schmid, Albert Wölfler, Marianne Brodmann
186 [GO] 2021―Jun―10 Narrative complexity in the time of COVID-19 Aline Gubrium, Erika Gubrium
187 [GO] 2021―Jun―10 From routine data collection to policy design: sex and gender both matter in COVID-19 Mireille Evagora-Campbell, Kakoli Borkotoky, Sneha Sharma, Michelle Mbuthia
188 [GO] 2021―Jun―10 COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply Sharon Amit, Gili Regev-Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem
189 [GO] 2021―Jun―10 COVID-19 vaccine efficacy data: solid enough to delay second dose? John F R Robertson, Herb F Sewell
190 [GO] 2021―Jun―10 Anticoagulation in COVID-19: reaction to the ACTION trial Jeffrey S Berger, Jean Marie Connors
191 [GO] 2021―Jun―10 A strategy for SARS-CoV-2 vaccination in Yemen Abdullah Nasser, Fathiah Zakham
192 [GO] 2021―Jun―10 ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates Elizabeth T Rogawski McQuade, James A Platts-Mills
193 [GO] 2021―Jun―10 ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply Merryn Voysey, Andrew J Pollard
194 [GO] 2021―Jun―08 Epidemiology, not geopolitics, should guide COVID-19 vaccine donations Thomas J Bollyky, Christopher J L Murray, Robert C Reiner
195 [GO] 2021―Jun―05 Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19 Emily Ying Yang Chan, Nina Gobat, Caroline Dubois, Jamie Bedson, Joao Rangel de Almeida
196 [GO] 2021―Jun―05 Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani, et al. (+42)
197 [GO] 2021―Jun―03 The CEPI centralised laboratory network: supporting COVID-19 vaccine development Arun Kumar, Valentina Bernasconi, Mark Manak, Ana Paula de Almeida Aranha, Paul A Kristiansen
198 [GO] 2021―Jun―03 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, et al. (+19)
199 [GO] 2021―Jun―02 Delayed COVID-19 vaccine roll-out in Japan Makoto Kosaka, Takanao Hashimoto, Akihiko Ozaki, Tetsuya Tanimoto, Masahiro Kami
200 [GO] 2021―Jun―01 A pandemic anniversary: 40 years of HIV/AIDS Chris Beyrer
201 [GO] 2021―May―29 Africa's need for more COVID-19 clinical trials Munyaradzi Makoni
202 [GO] 2021―May―29 Cambodia ends controversial COVID-19 restrictions Megan Tatum
203 [GO] 2021―May―28 Mutual aid, pandemic politics, and global social medicine in Brazil Dominique Béhague, Francisco Ortega
204 [GO] 2021―May―25 India's resurgence of COVID-19: urgent actions needed Yamini Aiyar, Vijay Chandru, Mirai Chatterjee, Sapna Desai, Armida Fernandez, Atul Gupta, et al. (+15)
205 [GO] 2021―May―21 Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study Bruce M Biccard, Pragasan Dean Gopalan, Malcolm Miller, William Lance Michell, David Thomson, Adesoji Ademuyiwa, et al. (+226)
206 [GO] 2021―May―21 What next for a COVID-19 intellectual property waiver? John Zarocostas
207 [GO] 2021―May―21 Excess COVID-19 mortality among critically ill patients in Africa Bruce J Kirenga, Pauline Byakika-Kibwika
208 [GO] 2021―May―21 Gendered effects of COVID-19 on young girls in regions of conflict Sophia N Nesamoney, Gary L Darmstadt, Paul H Wise
209 [GO] 2021―May―21 Refugee access to COVID-19 vaccines in Lebanon Nadine K Jawad, Lina Abu Taweeleh, Jad A Elharake, Nicole Khamis, Osaid Alser, Fatima M Karaki, Layla Aboukhater
210 [GO] 2021―May―14 India's COVID-19 crisis: a call for international action Krutika Kuppalli, Pooja Gala, Kartikeya Cherabuddi, S P Kalantri, Manoj Mohanan, Bhramar Mukherjee, et al. (+7)
211 [GO] 2021―May―14 Convalescent plasma in patients hospitalised with COVID-19 Sean T H Liu, Judith A Aberg
212 [GO] 2021―May―14 Disease surveillance for the COVID-19 era: time for bold changes Oliver W Morgan, Ximena Aguilera, Andrea Ammon, John Amuasi, Ibrahima Socé Fall, Tom Frieden, et al. (+10)
213 [GO] 2021―May―14 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+7188)
214 [GO] 2021―May―13 COVID-19 in Turkey: a nation on edge Kaya Genç
215 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function Philipp Enghard, Jan-Hendrik Hardenberg, Helena Stockmann, Christian Hinze, Kai-Uwe Eckardt, Kai M Schmidt-Ott
216 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function Pierre Delanaye, Justine Huart, Antoine Bouquegneau, François Jouret
217 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function - Authors' reply Lixue Huang, Xiaoying Gu, Yeming Wang, Chaolin Huang, Bin Cao
218 [GO] 2021―May―13 Serbia begins paying citizens to receive a COVID-19 vaccine Ed Holt
219 [GO] 2021―May―13 Canada is no global health leader on COVID-19 vaccine equity Adam R Houston, Srinivas Murthy
220 [GO] 2021―May―13 Global COVID-19 vaccine roll-out: time to randomise vaccine allocation? Samuel I Watson, Richard J Lilford
221 [GO] 2021―May―13 Venezuela is collapsing without COVID-19 vaccines Enrique S López Loyo, Marino J González, José Esparza
222 [GO] 2021―May―12 Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic Ellen Johnson Sirleaf, Helen Clark
223 [GO] 2021―May―12 Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data Robert H Shaw, Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S Nguyen Van-Tam, Matthew D Snape
224 [GO] 2021―May―07 LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19 Michael Anderson, Emma Pitchforth, Miqdad Asaria, Carol Brayne, Barbara Casadei, Anita Charlesworth, et al. (+28)
225 [GO] 2021―May―07 India's COVID-19 emergency The Lancet
226 [GO] 2021―May―07 Priorities for COVID-19 research response and preparedness in low-resource settings Alice Joan Norton, Charles Shey Wiysonge, Jean-Marie Vianney Habarugira, Nicholas John White, Marta Tufet Bayona, Hans-Eckhardt Hagen, et al. (+19)
227 [GO] 2021―May―07 COVID-19 surge threatens health in the Gaza strip Sharmila Devi
228 [GO] 2021―May―06 UK guidelines for managing long-term effects of COVID-19 Waqaar Shah, Melissa Heightman, Stella O'Brien
229 [GO] 2021―May―06 No-fault compensation schemes for COVID-19 medical products Yasuhiro Fujiwara, Yutaka Onda, Shuichiro Hayashi
230 [GO] 2021―May―05 Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan, et al. (+9)
231 [GO] 2021―May―05 COVID-19 vaccine impact in Israel and a way out of the pandemic Eyal Leshem, Annelies Wilder-Smith
232 [GO] 2021―Apr―30 Experts criticise India's complacency over COVID-19 Anoo Bhuyan
233 [GO] 2021―Apr―30 Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6343)
234 [GO] 2021―Apr―30 Tocilizumab in COVID-19: some clarity amid controversy Shruti Gupta, David E Leaf
235 [GO] 2021―Apr―30 COVID-19 and disparities affecting ethnic minorities Daniel R Morales, Sarah N Ali
236 [GO] 2021―Apr―30 Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform Rohini Mathur, Christopher T Rentsch, Caroline E Morton, William J Hulme, Anna Schultze, Brian MacKenna, et al. (+31)
237 [GO] 2021―Apr―28 SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties Miquel Oliu-Barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, et al. (+2)
238 [GO] 2021―Apr―28 A global pandemic treaty should aim for deep prevention Jorge Vinuales, Suerie Moon, Ginevra Le Moli, Gian-Luca Burci
239 [GO] 2021―Apr―23 COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, et al. (+349)
240 [GO] 2021―Apr―23 Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study Eleftheria Vasileiou, Colin R Simpson, Ting Shi, Steven Kerr, Utkarsh Agrawal, Ashley Akbari, et al. (+26)
241 [GO] 2021―Apr―23 Hospital admissions due to COVID-19 in Scotland after one dose of vaccine Natalie Dean
242 [GO] 2021―Apr―20 The Swedish COVID-19 strategy revisited Mariam Claeson, Stefan Hanson
243 [GO] 2021―Apr―17 COVID-19: time for ethical reflection? Henri-Corto Stoeklé, Achille Ivasilevitch, Christian Hervé
244 [GO] 2021―Apr―16 Brazilian ICUs short of drugs and beds amid COVID-19 surge Lise Alves
245 [GO] 2021―Apr―16 Ten scientific reasons in support of airborne transmission of SARS-CoV-2 Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufekci, David Fisman, Robert Schooley
246 [GO] 2021―Apr―16 Pandemic reading: poetry, looking and seeing Belinda Jack
247 [GO] 2021―Apr―15 Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Suraj Kadiwar, Jonathan J Smith, Stephane Ledot, Mark Johnson, Paolo Bianchi, Natasha Singh, et al. (+4)
248 [GO] 2021―Apr―15 Tanzania's position on the COVID-19 pandemic Sayoki G Mfinanga, Nicholaus P Mnyambwa, Daniel T Minja, Nyanda Elias Ntinginya, Esther Ngadaya, Julie Makani, Abel N Makubi
249 [GO] 2021―Apr―15 Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination Antonios Bayas, Martina Menacher, Monika Christ, Lars Behrens, Andreas Rank, Markus Naumann
250 [GO] 2021―Apr―09 Correlates of protection from SARS-CoV-2 infection Florian Krammer
251 [GO] 2021―Apr―09 SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Victoria Jane Hall, Sarah Foulkes, Andre Charlett, Ana Atti, Edward J Monk, Ruth Simmons, et al. (+323)
252 [GO] 2021―Apr―08 US-China health exchange and collaboration following COVID-19 Liming Li, Kean Wang, Zhuo Chen, Jeffrey P Koplan
253 [GO] 2021―Apr―08 China's response to COVID-19: a chance for collaboration The Lancet
254 [GO] 2021―Apr―08 Calls for transparency after SARS-CoV-2 origins report John Zarocostas
255 [GO] 2021―Apr―07 Ramadan and COVID-19 vaccine hesitancy-a call for action Sarah N Ali, Wasim Hanif, Kiran Patel, Kamlesh Khunti
256 [GO] 2021―Apr―02 Migration and health in Latin America during the COVID-19 pandemic and beyond Ietza Bojorquez, Báltica Cabieses, Carlos Arósquipa, Juan Arroyo, Andrés Cubillos Novella, Michael Knipper, et al. (+3)
257 [GO] 2021―Apr―02 COVID-19 vaccines in high-risk ethnic groups Rashmi S D'Souza, Ingrid Wolfe
258 [GO] 2021―Apr―02 Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 Justin E R E Wong Chung, Ö Engin, T F W Wolfs, T J C Renson, J H de Boer
259 [GO] 2021―Apr―02 Leveraging data and new digital tools to prepare for the next pandemic Sally C Davies, Hala Audi, Mitch Cuddihy
260 [GO] 2021―Mar―31 Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence? Søren Dinesen Østergaard, Morten Schmidt, Erzsébet Horváth-Puhó, Reimar Wernich Thomsen, Henrik Toft Sørensen
261 [GO] 2021―Mar―31 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, Cristina V Ariani, Brian Angus, Sagida Bibi, et al. (+58)
262 [GO] 2021―Mar―31 Pandemic moves and countermoves: vaccines and viral variants Rogier W Sanders, Menno D de Jong
263 [GO] 2021―Mar―25 COVID-19, cults, and the anti-vax movement Sophie Mylan, Charlotte Hardman
264 [GO] 2021―Mar―25 New COVID-19 resurgence in the WHO Eastern Mediterranean region Pierre Nabeth, Mahmoud Hassan, Keyrellous Adib, Abdinasir Abubakar, Richard Brennan
265 [GO] 2021―Mar―25 Uncertainties over EU COVID-19 vaccine sharing scheme Ann Danaiya Usher
266 [GO] 2021―Mar―25 COVID-19 vaccines for the European region: an unprecedented challenge Hans Kluge, Martin McKee
267 [GO] 2021―Mar―25 COVID-19: building a stronger Europe The Lancet
268 [GO] 2021―Mar―24 Gender, race, and health workers in the COVID-19 pandemic Gabriela Lotta, Michelle Fernandez, Denise Pimenta, Clare Wenham
269 [GO] 2021―Mar―24 Africa needs local solutions to face the COVID-19 pandemic Yap Boum, Lisa M Bebell, Anne-Cécile Zoung-Kanyi Bisseck
270 [GO] 2021―Mar―24 The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study Stephanie J Salyer, Justin Maeda, Senga Sembuche, Yenew Kebede, Akhona Tshangela, Mohamed Moussif, et al. (+5)
271 [GO] 2021―Mar―24 Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights Chris Beyrer, Pascale Allotey, Joseph J Amon, Stefan D Baral, Mary T Bassett, Harriet Deacon, et al. (+17)
272 [GO] 2021―Mar―23 Guidelines should not pool evidence from uncomplicated and severe COVID-19 Nicholas J White, Nathalie Strub-Wourgaft, Abul Faiz, Philippe J Guerin
273 [GO] 2021―Mar―23 Assessing government responsibility for COVID-19 deaths Adrian P Mundt
274 [GO] 2021―Mar―23 Rapid identification and tracking of SARS-CoV-2 variants of concern Debojyoti Chakraborty, Anurag Agrawal, Souvik Maiti
275 [GO] 2021―Mar―23 Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection Salim S Abdool Karim
276 [GO] 2021―Mar―19 Biden's first legislative victory: $1·9 trillion for COVID-19 Susan Jaffe
277 [GO] 2021―Mar―19 COVID-19, community trials, and inclusion Paramjit S Gill, Shoba Poduval, Jarnail S Thakur, Romaina Iqbal
278 [GO] 2021―Mar―19 Free licensing of vaccines to end the COVID-19 crisis Kayvan Bozorgmehr, Rosa Jahn, David Stuckler, Martin McKee
279 [GO] 2021―Mar―19 Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2 Richard Strugnell, Nancy Wang
280 [GO] 2021―Mar―18 Triple jeopardy: disabled people and the COVID-19 pandemic Tom Shakespeare, Florence Ndagire, Queen E Seketi
281 [GO] 2021―Mar―18 Malnutrition risk in hospitalised COVID-19 patients receiving CPAP Pete Turner, Hugh Montgomery, Mike Stroud, George Grimble, Trevor Smith
282 [GO] 2021―Mar―18 Missing again: US racial and ethnic data for COVID-19 vaccination Nancy Krieger, Pamela D Waterman, Jarvis T Chen, Christian Testa, William P Hanage
283 [GO] 2021―Mar―18 Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study Christian Holm Hansen, Daniela Michlmayr, Sophie Madeleine Gubbels, Kåre Mølbak, Steen Ethelberg
284 [GO] 2021―Mar―18 Risk of SARS-CoV-2 reinfection after natural infection Rosemary J Boyton, Daniel M Altmann
285 [GO] 2021―Mar―12 School reopening without robust COVID-19 mitigation risks accelerating the pandemic Deepti Gurdasani, Nisreen A Alwan, Trisha Greenhalgh, Zoë Hyde, Luke Johnson, Martin McKee, et al. (+6)
286 [GO] 2021―Mar―12 A shared COVID-19 testimony Rageshri Dhairyawan
287 [GO] 2021―Mar―12 Countries split from EU on COVID-19 vaccines Ed Holt
288 [GO] 2021―Mar―12 Access to COVID-19 vaccines: looking beyond COVAX The Lancet
289 [GO] 2021―Mar―09 18Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine Julie Steinberg, Alex Thomas, Amir Iravani
290 [GO] 2021―Mar―07 The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response Syra Madad, Craig Spencer
291 [GO] 2021―Mar―07 Sex-disaggregated data in COVID-19 vaccine trials Lavanya Vijayasingham, Evelyne Bischof, Jeannette Wolfe
292 [GO] 2021―Mar―05 Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Christopher C Butler, Jienchi Dorward, Ly-Mee Yu, Oghenekome Gbinigie, Gail Hayward, Benjamin R Saville, et al. (+12)
293 [GO] 2021―Mar―05 Medical oxygen crisis: a belated COVID-19 response Ann Danaiya Usher
294 [GO] 2021―Mar―05 Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster Ivan F N Hung, Gregory A Poland
295 [GO] 2021―Feb―26 New WTO leader faces COVID-19 challenges John Zarocostas
296 [GO] 2021―Feb―26 Historical evidence to inform COVID-19 vaccine mandates Rajaie Batniji
297 [GO] 2021―Feb―26 Peruvian COVID-19 vaccine scandal spreads Lucien Chauvin
298 [GO] 2021―Feb―26 Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine Maria Prendecki, Candice Clarke, Jonathan Brown, Alison Cox, Sarah Gleeson, Mary Guckian, et al. (+8)
299 [GO] 2021―Feb―26 Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals Charlotte Manisty, Ashley D Otter, Thomas A Treibel, Áine McKnight, Daniel M Altmann, Timothy Brooks, et al. (+4)
300 [GO] 2021―Feb―26 Offline: Thinking the pandemic Richard Horton
301 [GO] 2021―Feb―24 The changing face of medical professionalism and the impact of COVID-19 Andrew F Goddard, Mumtaz Patel
302 [GO] 2021―Feb―24 UK COVID-19 public inquiry and lessons from patient safety David K Whitaker
303 [GO] 2021―Feb―21 Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients Sharon Amit, Gili Regev-Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem
304 [GO] 2021―Feb―21 MAb for symptomatic COVID-19 in correctional facilities: an important opportunity Justin Berk, Lauren Brinkley-Rubinstein, Matthew Murphy, Phil Chan, Josiah Rich
305 [GO] 2021―Feb―21 Same script, different viruses: HIV and COVID-19 in US Black communities Errol L Fields, Raniyah Copeland, Ernest Hopkins
306 [GO] 2021―Feb―21 von der Leyen admits to COVID-19 vaccine failures Rob Hyde
307 [GO] 2021―Feb―21 Severe mental illness: reassessing COVID-19 vaccine priorities Nayanah Siva
308 [GO] 2021―Feb―21 Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs Ivan Sisa, Estefania Noblecilla, Fadya Orozco
309 [GO] 2021―Feb―21 Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, et al. (+760)
310 [GO] 2021―Feb―18 Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19 Michael J Mina, Tim E Peto, Marta García-Fiñana, Malcolm G Semple, Iain E Buchan
311 [GO] 2021―Feb―17 Future scenarios for the COVID-19 pandemic David Skegg, Peter Gluckman, Geoffrey Boulton, Heide Hackmann, Salim S Abdool Karim, Peter Piot, Christiane Woopen
312 [GO] 2021―Feb―15 Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment Olivier J Wouters, Kenneth C Shadlen, Maximilian Salcher-Konrad, Andrew J Pollard, Heidi J Larson, Yot Teerawattananon, Mark Jit
313 [GO] 2021―Feb―15 Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission Jeffrey D Sachs, Salim Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Gabriela Cuevas Barron, et al. (+30)
314 [GO] 2021―Feb―11 COVID-19 in Brazil: far beyond biopolitics Rafael Dall'Alba, Cristianne Famer Rocha, Roberta de Pinho Silveira, Liciane da Silva Costa Dresch, Luciana Araújo Vieira, Marco André Germanò
315 [GO] 2021―Feb―11 SARS-CoV-2 variants and ending the COVID-19 pandemic Arnaud Fontanet, Brigitte Autran, Bruno Lina, Marie Paule Kieny, Salim S Abdool Karim, Devi Sridhar
316 [GO] 2021―Feb―11 Tanzania refuses COVID-19 vaccines Munyaradzi Makoni
317 [GO] 2021―Feb―10 Ensure Palestinians have access to COVID-19 vaccines Steven Martin, Thalia Arawi
318 [GO] 2021―Feb―05 Offline: COVID-19 and the convergence of nations Richard Horton
319 [GO] 2021―Feb―05 Calling for benefit-risk evaluations of COVID-19 control measures Günter Kampf, Martin Kulldorff
320 [GO] 2021―Feb―05 A COVID-19 jab in the right direction A Mark Clarfield, Karl Skorecki, Orly Manor, Shimon Glick
321 [GO] 2021―Feb―05 WHO team begins COVID-19 origin investigation John Zarocostas
322 [GO] 2021―Feb―05 WHO international non-proprietary names: the need to distinguish COVID-19 vaccines Ursula Loizides, Akinola Adisa, Ana López de la Rica Manjavacas, James S Robertson, Raffaella Balocco
323 [GO] 2021―Feb―05 Understanding variants of SARS-CoV-2 Talha Burki
324 [GO] 2021―Feb―05 Genomic sequencing in pandemics The Lancet
325 [GO] 2021―Feb―05 Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, Alfie Abbott, Ashraf Abdelaziz, Sherif Abdelbadiee, et al. (+5364)
326 [GO] 2021―Feb―02 COVID-19, structural racism, and migrant health in Canada Germaine Tuyisenge, Shira M Goldenberg
327 [GO] 2021―Feb―02 Sputnik V COVID-19 vaccine candidate appears safe and effective Ian Jones, Polly Roy
328 [GO] 2021―Feb―02 COVID-19 vaccine research and the trouble with clinical equipoise Phoebe Friesen, Arthur L Caplan, Jennifer E Miller
329 [GO] 2021―Feb―02 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, et al. (+25)
330 [GO] 2021―Jan―29 Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial Peter Richmond, Lara Hatchuel, Min Dong, Brenda Ma, Branda Hu, Igor Smolenov, et al. (+5)
331 [GO] 2021―Jan―29 Next-generation COVID-19 vaccines: here come the proteins Anna K Blakney, Paul F McKay
332 [GO] 2021―Jan―28 Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics J Peter Figueroa, Maria Elena Bottazzi, Peter Hotez, Carolina Batista, Onder Ergonul, Sarah Gilbert, et al. (+12)
333 [GO] 2021―Jan―28 COVID-19 vaccines for Palestinians Graham Watt, Rita Giacaman, Huda Zurayk, Espen Bjertness, Gerd Holmboe-Ottesen, Hala Ghattas, et al. (+8)
334 [GO] 2021―Jan―28 Caring intensively: a GP's pandemic journal Rachel Clarke
335 [GO] 2021―Jan―28 SARS-CoV-2 serosurveys in low-income and middle-income countries Jean Claude Mugunga, Kartik Tyagi, Daniel Bernal-Serrano, Nidia Correa, Matias Iberico, Frederick Kateera, et al. (+4)
336 [GO] 2021―Jan―27 Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence Ester C Sabino, Lewis F Buss, Maria P S Carvalho, Carlos A Prete, Myuki A E Crispim, Nelson A Fraiji, et al. (+17)
337 [GO] 2021―Jan―25 The need for a global COVID-19 maternal immunisation research plan Azucena Bardají, Esperança Sevene, Clare Cutland, Clara Menéndez, Saad B Omer, Teresa Aguado, Flor M Muñoz
338 [GO] 2021―Jan―22 COVID-19 and the moral imagination Mahomed Said Patel, Christine Beatrice Phillips
339 [GO] 2021―Jan―22 Reaffirming health and safety precautionary principles for COVID-19 in the UK Raymond M Agius, Denise Kendrick, Herb F Sewell, Marcia Stewart, John FR Robertson
340 [GO] 2021―Jan―22 India begins COVID-19 vaccination amid trial allegations Anoo Bhuyan
341 [GO] 2021―Jan―22 COVID-19: the intersection of education and health The Lancet
342 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection Kristof Egervari, Christian Thomas, Johannes A Lobrinus, Tanja Kuhlmann, Wolfgang Brück, Seth Love, et al. (+4)
343 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection MacLean P Nasrallah, Zissimos Mourelatos, Edward B Lee
344 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection Markus Glatzel, Christian Hagel, Jakob Matschke, Jan Sperhake, Nikolaus Deigendesch, Alexandar Tzankov, Stephan Frank
345 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection - Authors' reply Claus Hann von Weyhern, Ines Kaufmann, Frauke Neff, Marcus Kremer
346 [GO] 2021―Jan―22 South Africa responds to new SARS-CoV-2 variant Munyaradzi Makoni
347 [GO] 2021―Jan―21 An action plan for pan-European defence against new SARS-CoV-2 variants Viola Priesemann, Rudi Balling, Melanie M Brinkmann, Sandra Ciesek, Thomas Czypionka, Isabella Eckerle, et al. (+11)
348 [GO] 2021―Jan―20 Preparing for a COVID-19 resurgence in the WHO African region Benido Impouma, Franck Mboussou, Francis Kasolo, Zabulon Yoti, Matshidiso R Moeti
349 [GO] 2021―Jan―15 COVID-19 highlights Canada's care home crisis Paul Webster
350 [GO] 2021―Jan―15 Using EM data to understand COVID-19 pathophysiology Marisa Dolhnikoff, Amaro N Duarte-Neto, Paulo H N Saldiva, Elia G Caldini
351 [GO] 2021―Jan―15 Using EM data to understand COVID-19 pathophysiology - Authors' reply Carsten Dittmayer, Jenny Meinhardt, Helena Radbruch, Josefine Radke, Barbara Ingold Heppner, Frank L Heppner, et al. (+3)
352 [GO] 2021―Jan―14 The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines Marco Cavaleri, Harald Enzmann, Sabine Straus, Emer Cooke
353 [GO] 2021―Jan―11 Long-term follow-up of recovered patients with COVID-19 Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
354 [GO] 2021―Jan―11 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Chaolin Huang, Lixue Huang, Yeming Wang, Xia Li, Lili Ren, Xiaoying Gu, et al. (+26)
355 [GO] 2021―Jan―08 Parenting in the time of COVID-19 Shana Kusin, Esther Choo
356 [GO] 2021―Jan―08 Health systems neglected by COVID-19 donors Ann Danaiya Usher
357 [GO] 2021―Jan―08 ECMO support for COVID-19: a balancing act Yang Zhang, Bingyang Ji, Zhou Zhou
358 [GO] 2021―Jan―08 ECMO support for COVID-19: a balancing act - Authors' reply Ryan P Barbaro, Graeme MacLaren, Daniel Brodie
359 [GO] 2020―Dec―23 COVID-19 and the Swedish enigma Mariam Claeson, Stefan Hanson
360 [GO] 2020―Dec―23 UK COVID-19 public inquiry needed to learn lessons and save lives Jo Goodman, Kathryn de Prudhoe, Charlie Williams
361 [GO] 2020―Dec―23 COVID-19 vaccines and women's security Sophie Harman, Asha Herten-Crabb, Rosemary Morgan, Julia Smith, Clare Wenham
362 [GO] 2020―Dec―18 Offline: The lessons of smallpox eradication for COVID-19 Richard Horton
363 [GO] 2020―Dec―18 Infectivity of asymptomatic versus symptomatic COVID-19 Andrew A Sayampanathan, Cheryl S Heng, Phua Hwee Pin, Junxiong Pang, Teoh Yee Leong, Vernon J Lee
364 [GO] 2020―Dec―18 Science during COVID-19: where do we go from here? The Lancet
365 [GO] 2020―Dec―18 Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections Viola Priesemann, Melanie M Brinkmann, Sandra Ciesek, Sarah Cuschieri, Thomas Czypionka, Giulia Giordano, et al. (+14)
366 [GO] 2020―Dec―16 Pay gaps in medicine and the impact of COVID-19 on doctors' careers Carol Woodhams, Jane Dacre, Ira Parnerkar, Mukunda Sharma
367 [GO] 2020―Dec―16 Reduced mortality in New Zealand during the COVID-19 pandemic Stacey Kung, Marjan Doppen, Melissa Black, Tom Hills, Nethmi Kearns
368 [GO] 2020―Dec―16 Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests Meagan C Fitzpatrick, Abhishek Pandey, Chad R Wells, Pratha Sah, Alison P Galvani
369 [GO] 2020―Dec―11 Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic Berit Lange
370 [GO] 2020―Dec―11 Experts call to include prisons in COVID-19 vaccine plans Nayanah Siva
371 [GO] 2020―Dec―11 The COVID-19 vaccines rush: participatory community engagement matters more than ever Rochelle Ann Burgess, Richard H Osborne, Kenneth A Yongabi, Trisha Greenhalgh, Deepti Gurdasani, Gagandeep Kang, et al. (+6)
372 [GO] 2020―Dec―11 Is my cough COVID-19? Eric J Topol
373 [GO] 2020―Dec―11 Association of SARS-CoV-2 renal tropism with acute kidney injury Kay Weng Choy
374 [GO] 2020―Dec―11 Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply Fabian Braun, Carolin Edler, Victor G Puelles, Tobias B Huber
375 [GO] 2020―Dec―11 The infective nurture of pandemic comics Ciléin Kearns, Dale Fisher, Yap Seng Chong
376 [GO] 2020―Dec―11 One Health or Planetary Health for pandemic prevention? Courtney Waugh, Su Shiung Lam, Christian Sonne
377 [GO] 2020―Dec―11 One Health or Planetary Health for pandemic prevention? - Authors' reply John H Amuasi, Andrea S Winkler
378 [GO] 2020―Dec―08 Oxford-AstraZeneca COVID-19 vaccine efficacy Maria Deloria Knoll, Chizoba Wonodi
379 [GO] 2020―Dec―08 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, et al. (+757)
380 [GO] 2020―Dec―04 Is NHS Test and Trace exacerbating COVID-19 inequalities? Adam D M Briggs, Caroline Fraser
381 [GO] 2020―Dec―03 An African plan to control COVID-19 is urgently needed The Lancet
382 [GO] 2020―Dec―03 South Africa and India push for COVID-19 patents ban Ann Danaiya Usher
383 [GO] 2020―Dec―03 Offline: COVID-19-what have we learned so far? Richard Horton
384 [GO] 2020―Dec―02 Climate and COVID-19: converging crises The Lancet
385 [GO] 2020―Dec―01 Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage Arush Lal, Ngozi A Erondu, David L Heymann, Githinji Gitahi, Robert Yates
386 [GO] 2020―Nov―30 Centring adolescent girls and young women in the HIV and COVID-19 responses Ameena Goga, Linda Gail Bekker, Philippe Van de Perre, Wafaa El-Sadr, Khatija Ahmed, Mookho Malahleha, et al. (+4)
387 [GO] 2020―Nov―26 Applying for residency in the time of COVID-19 Tema Fodje, Esther Choo
388 [GO] 2020―Nov―26 A tribute to some of the doctors who died from COVID-19 Andrew Green
389 [GO] 2020―Nov―26 Maintaining the HIV response in a world shaped by COVID-19 The Lancet
390 [GO] 2020―Nov―26 Afghanistan braced for second wave of COVID-19 Sophie Cousins
391 [GO] 2020―Nov―26 Offline: Europe and COVID-19-struggling with tragedy Richard Horton
392 [GO] 2020―Nov―24 Smart system of disease management for patient follow-up and medication refill during the COVID-19 epidemic period: a multicentre retrospective cohort study Lingli Dong, Anbin Huang, Shengtao Zhang, Yikai Yu, Shouxin li, Lingxun Shen, et al. (+4)
393 [GO] 2020―Nov―24 The attitude and psychological status of medical staff in China during the COVID-19 outbreak: a cross-sectional survey Ziyi Yan, Yali Cui, Wen Chen, Mingjing Yu, Qichen Long, Yunyi Yuan, et al. (+4)
394 [GO] 2020―Nov―20 Urgent actions and policies needed to address COVID-19 among UK ethnic minorities Rohini Mathur, Laura Bear, Kamlesh Khunti, Rosalind M Eggo
395 [GO] 2020―Nov―20 Tackling COVID-19 in the Eastern Mediterranean Region Ahmed Salim Al-Mandhari, Richard J Brennan, Abdinasir Abubakar, Rana Hajjeh
396 [GO] 2020―Nov―20 COVID-19 vaccines: no time for complacency The Lancet
397 [GO] 2020―Nov―20 Notice of addendum to Article reporting Oxford trial of ChAdOx1 nCoV-19 vaccine Andrew J Pollard
398 [GO] 2020―Nov―19 Age and frailty in COVID-19 vaccine development Melissa K Andrew, Janet E McElhaney
399 [GO] 2020―Nov―19 Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, Amy L Flaxman, Pedro M Folegatti, Daniel R Owens, et al. (+406)
400 [GO] 2020―Nov―12 Leveraging the COVID-19 response to end preventable child deaths from pneumonia Henrietta H Fore, Tedros Adhanom Ghebreyesus, Kevin Watkins, Leith Greenslade, Seth Berkley, Quique Bassat, et al. (+3)
401 [GO] 2020―Nov―12 Staying sane in our new COVID-19 world Devi Sridhar
402 [GO] 2020―Nov―10 COVID-19 in Brazil: the headlines should be about science André Zimerman, Renato D Lopes, André D'Ávila, Luis E Rohde, Leandro I Zimerman
403 [GO] 2020―Nov―09 The UK needs a sustainable strategy for COVID-19 Deepti Gurdasani, Laura Bear, Debby Bogaert, Rochelle A Burgess, Reinhard Busse, Roberto Cacciola, et al. (+30)
404 [GO] 2020―Nov―06 Early triple antiviral therapy for COVID-19 Nelson Lee, Michael Ison, Jake Dunning
405 [GO] 2020―Nov―06 Early triple antiviral therapy for COVID-19 - Authors' reply Ivan Fan-Ngai Hung, Kwok-Yung Yuen
406 [GO] 2020―Nov―06 COVID-19 in Latin America: a humanitarian crisis The Lancet
407 [GO] 2020―Nov―06 Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations Victor J Dzau, Celynne Balatbat
408 [GO] 2020―Nov―06 Institutional versus home isolation to curb the COVID-19 outbreak Ajeet Singh Bhadoria, Kanchan Gawande, Rachit Sharma, Archisman Mohapatra, Ravi Kant
409 [GO] 2020―Nov―06 Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply Annelies Wilder-Smith, Alex R Cook, Borame L Dickens
410 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Lewis Meecham, Julien Al Shakarchi, Habib P Rahman, Isaac K Nyamekye
411 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Seenu Vuthaluru, Sreedharan V Koliyadan, Sureshkannan S Kanniwadi
412 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Harsha Shanthanna, Vishal Uppal
413 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Jeremy Rodrigues, James K-K Chan, Fadi Issa
414 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Joseph Alderman
415 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Hytham K S Hamid
416 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic - Authors' reply COVIDSurg Collaborative
417 [GO] 2020―Nov―06 Offline: Managing the COVID-19 vaccine infodemic Richard Horton
418 [GO] 2020―Nov―06 Emergency use authorisation for COVID-19 vaccines: lessons from Ebola Maxwell J Smith, Samuel Ujewe, Rachel Katz, Ross E G Upshur
419 [GO] 2020―Nov―06 ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 Archie Lodge
420 [GO] 2020―Nov―06 ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 Anil Chauhan, Amit Agarwal, Nishant Jaiswal, Meenu Singh
421 [GO] 2020―Nov―06 ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply Merryn Voysey, Andrew J Pollard
422 [GO] 2020―Nov―06 SARS-CoV-2 seroprevalence in Spain Christian Hoffmann, Eva Wolf
423 [GO] 2020―Nov―06 SARS-CoV-2 seroprevalence in Spain Thukalan Paulose George
424 [GO] 2020―Nov―06 SARS-CoV-2 seroprevalence in Spain - Authors' reply Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Jesús Oteo, Mayte Pérez-Olmeda, Raquel Yotti
425 [GO] 2020―Nov―05 Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination Roy M Anderson, Carolin Vegvari, James Truscott, Benjamin S Collyer
426 [GO] 2020―Nov―03 Widespread smell testing for COVID-19 has limited application Claire Hopkins, Barry Smith
427 [GO] 2020―Nov―03 Widespread smell testing for COVID-19 has limited application - Authors' reply Cristina Menni, Carole H Sudre, Claire J Steves, Sebastien Ourselin, Tim D Spector
428 [GO] 2020―Oct―30 Asymptomatic health-care worker screening during the COVID-19 pandemic Angela Chow, Htet Lin Htun, Win Mar Kyaw, Lay Tin Lee, Brenda Ang
429 [GO] 2020―Oct―30 Organ procurement and transplantation in Germany during the COVID-19 pandemic Zhi Qu, Carina Oedingen, Tim Bartling, Harald Schrem, Christian Krauth
430 [GO] 2020―Oct―30 Asymptomatic health-care worker screening during the COVID-19 pandemic Kevin Fennelly, Christopher C Whalen
431 [GO] 2020―Oct―30 Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply Thomas A Treibel, Charlotte Manisty, Mervyn Andiapen, Corinna Pade, Melanie Jensen, Marianna Fontana, et al. (+4)
432 [GO] 2020―Oct―30 Host or pathogen-related factors in COVID-19 severity? Christian Gortázar, Francisco J Rodríguez del-Río, Lucas Domínguez, José de la Fuente
433 [GO] 2020―Oct―30 Host or pathogen-related factors in COVID-19 severity? - Authors' reply Lucy C Okell, Robert Verity, Aris Katzourakis, Erik M Volz, Oliver J Watson, Swapnil Mishra, et al. (+9)
434 [GO] 2020―Oct―30 Offline: COVID-19-a crisis of power Richard Horton
435 [GO] 2020―Oct―30 Slovakia to test all adults for SARS-CoV-2 Ed Holt
436 [GO] 2020―Oct―30 Transplant programmes in areas with high SARS-CoV-2 transmission Srikanth Reddy, Richard Dumbill, M Zeeshan Akhtar, Venkatesha Udupa, Ben M Storey, James Gilbert, et al. (+12)
437 [GO] 2020―Oct―27 Syndemic responses to COVID-19 should include an ecological dimension Chris Kenyon
438 [GO] 2020―Oct―27 Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential Philip R Krause, Thomas R Fleming, Susan S Ellenberg, Ana Maria Henao-Restrepo, PR Krause, T Fleming, et al. (+10)
439 [GO] 2020―Oct―27 Who should be prioritised for COVID-19 vaccines? Zaki Hassan-Smith, Wasim Hanif, Kamlesh Khunti
440 [GO] 2020―Oct―23 Experts criticise Australia's aged care failings over COVID-19 Sophie Cousins
441 [GO] 2020―Oct―23 Offline: Science and politics in the era of COVID-19 Richard Horton
442 [GO] 2020―Oct―23 US racial and ethnic data for COVID-19 cases: still missing in action Nancy Krieger, Christian Testa, William P Hanage, Jarvis T Chen
443 [GO] 2020―Oct―23 SARS-CoV-2 risk misclassification explains poor COVID-19 management Juan Martínez Hernández
444 [GO] 2020―Oct―23 Building a tuberculosis-free world while responding to the COVID-19 pandemic Michael J A Reid, Sachin Silva, Nimalan Arinaminpathy, Eric Goosby
445 [GO] 2020―Oct―23 Influenza control during the COVID-19 pandemic Thomas Hills, Nethmi Kearns, Ciléin Kearns, Richard Beasley
446 [GO] 2020―Oct―23 The COVID-19 syndemic is not global: context matters Emily Mendenhall
447 [GO] 2020―Oct―23 Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK - Authors' reply James R M Black, Chris Bailey, Joanna Przewrocka, Krijn K Dijkstra, Sonia Gandhi, Steve Gamblin, et al. (+2)
448 [GO] 2020―Oct―23 Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK Bernard Freudenthal
449 [GO] 2020―Oct―20 The Brazilian Government's mistakes in responding to the COVID-19 pandemic Sabrina Ferigato, Michelle Fernandez, Melania Amorim, Ilana Ambrogi, Luísa M M Fernandes, Rafaela Pacheco
450 [GO] 2020―Oct―20 Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response Ruth Stewart, Amena El-Harakeh, Sunu Alice Cherian
451 [GO] 2020―Oct―19 Science misuse and polarised political narratives in the COVID-19 response Rômulo Paes-Sousa, Christopher Millett, Rudi Rocha, Mauricio L Barreto, Thomas Hone
452 [GO] 2020―Oct―16 Unnecessary obstacles to COVID-19 mass testing Julian Peto, David J Hunter, Elio Riboli, Julian L Griffin
453 [GO] 2020―Oct―15 The Lombardy region of Italy launches the first investigative COVID-19 commission Michele Usuelli
454 [GO] 2020―Oct―15 Scientific consensus on the COVID-19 pandemic: we need to act now Nisreen A Alwan, Rochelle Ann Burgess, Simon Ashworth, Rupert Beale, Nahid Bhadelia, Debby Bogaert, et al. (+25)
455 [GO] 2020―Oct―13 SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates Gregory A Poland, Inna G Ovsyannikova, Richard B Kennedy
456 [GO] 2020―Oct―12 Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers Mark Honigsbaum, Lakshmi Krishnan
457 [GO] 2020―Oct―09 Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 Jean Carlet, Didier Payen, Steven M Opal
458 [GO] 2020―Oct―08 Cancer and COVID-19 Dimitrios Moris, Diamantis I Tsilimigras, Dimitrios Schizas
459 [GO] 2020―Oct―08 Cancer and COVID-19 Alexandre E Malek, Issam I Raad, Elias Jabbour
460 [GO] 2020―Oct―08 Cancer and COVID-19 - Authors' reply Nicole M Kuderer, Elizabeth Wulff-Burchfield, Samuel M Rubinstein, Petros Grivas, Jeremy L Warner
461 [GO] 2020―Oct―08 Is COVID-19 being used as a weapon against Indigenous Peoples in Brazil? Philippe Charlier, Leandro Varison
462 [GO] 2020―Oct―08 COVID-19, comics, and the visual culture of contagion Brian Callender, Shirlene Obuobi, M K Czerwiec, Ian Williams
463 [GO] 2020―Oct―08 Study of critically ill patients with COVID-19 in New York City Daniele Piovani, Stefanos Bonovas
464 [GO] 2020―Oct―08 Study of critically ill patients with COVID-19 in New York City - Authors' reply Matthew J Cummings, Max R O'Donnell
465 [GO] 2020―Oct―08 Undermining breastfeeding will not alleviate the COVID-19 pandemic Natalie S Shenker, Aleksandra Wesolowska, Johannes B van Goudoever, Sushma Nangia, Daniel Klotz
466 [GO] 2020―Oct―08 2·5 million more child marriages due to COVID-19 pandemic Sophie Cousins
467 [GO] 2020―Oct―08 Marketing of breastmilk substitutes during the COVID-19 pandemic Christoffer van Tulleken, Charlotte Wright, Amy Brown, David McCoy, Anthony Costello
468 [GO] 2020―Oct―08 Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply Rüdiger Groß, Carina Conzelmann, Janis A Müller, Frank Reister, Frank Kirchhoff, Jan Münch
469 [GO] 2020―Oct―08 Living with the COVID-19 pandemic: act now with the tools we have Juliet Bedford, Delia Enria, Johan Giesecke, David L Heymann, Chikwe Ihekweazu, Gary Kobinger, et al. (+6)
470 [GO] 2020―Oct―08 COVID-19: leaving no one behind in Latin America Alice Blukacz, Baltica Cabieses
471 [GO] 2020―Oct―05 Antiviral monotherapy for hospitalised patients with COVID-19 is not enough Bin Cao, Frederick G Hayden
472 [GO] 2020―Oct―05 Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Peter W Horby, Marion Mafham, Jennifer L Bell, Louise Linsell, Natalie Staplin, Jonathan Emberson, et al. (+20)
473 [GO] 2020―Oct―05 Power of and power over COVID-19 response guidelines Kayvan Bozorgmehr
474 [GO] 2020―Oct―05 Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral Carsten Dittmayer, Jenny Meinhardt, Helena Radbruch, Josefine Radke, Barbara Ingold Heppner, Frank L Heppner, et al. (+3)
475 [GO] 2020―Oct―01 Leveraging the advances in HIV for COVID-19 James H McMahon, Jennifer F Hoy, Adeeba Kamarulzaman, Linda-Gail Bekker, Chris Beyrer, Sharon R Lewin
476 [GO] 2020―Oct―01 Remdesivir and COVID-19 Matthew J Glaus, Serena Von Ruden
477 [GO] 2020―Oct―01 Remdesivir and COVID-19 Jessie K Edwards, Stephen R Cole, Adaora A Adimora
478 [GO] 2020―Oct―01 Remdesivir and COVID-19 Lei-Yun Wang, Jia-Jia Cui, Qian-Ying Ouyang, Yan Zhan, Cheng-Xian Guo, Ji-Ye Yin
479 [GO] 2020―Oct―01 Remdesivir and COVID-19 Alicia Dennis
480 [GO] 2020―Oct―01 Remdesivir and COVID-19 - Authors' reply Yeming Wang, Xiaoying Gu, Jiuyang Xu, Bin Cao, Chen Wang
481 [GO] 2020―Oct―01 Building a resilient NHS, for COVID-19 and beyond The Lancet
482 [GO] 2020―Oct―01 Minimising long-term effect of COVID-19 in dementia care Karen Harrison Dening, Mari Lloyd-Williams
483 [GO] 2020―Sep―29 Lockdown impact on COVID-19 epidemics in regions across metropolitan France Simon Cauchemez, Cécile Tran Kiem, Juliette Paireau, Patrick Rolland, Arnaud Fontanet
484 [GO] 2020―Sep―29 Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election Steffanie A Strathdee, Sally C Davies, Jasmine R Marcelin
485 [GO] 2020―Sep―25 Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry Ryan P Barbaro, Graeme MacLaren, Philip S Boonstra, Theodore J Iwashyna, Arthur S Slutsky, Eddy Fan, et al. (+195)
486 [GO] 2020―Sep―25 Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study Shuchi Anand, Maria Montez-Rath, Jialin Han, Julie Bozeman, Russell Kerschmann, Paul Beyer, et al. (+2)
487 [GO] 2020―Sep―25 SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA Barnaby Flower, Christina Atchison
488 [GO] 2020―Sep―24 David Hare's fiery account of COVID-19 Philip Ball
489 [GO] 2020―Sep―24 COVID-19 in India: the dangers of false optimism The Lancet
490 [GO] 2020―Sep―24 Offline: COVID-19 is not a pandemic Richard Horton
491 [GO] 2020―Sep―24 Models for mortality require tailoring in the context of the COVID-19 pandemic Arielle Lasry, Roberta Horth
492 [GO] 2020―Sep―24 Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic Zion Hagay
493 [GO] 2020―Sep―24 Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply Amitava Banerjee, Laura Pasea, Spiros Denaxas, Bryan Williams, Harry Hemingway
494 [GO] 2020―Sep―24 Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe Emeline Han, Melisa Mei Jin Tan, Eva Turk, Devi Sridhar, Gabriel M Leung, Kenji Shibuya, et al. (+11)
495 [GO] 2020―Sep―22 The Riyadh Declaration: the role of digital health in fighting pandemics Bandar Al Knawy, Mahmood Adil, George Crooks, Kyu Rhee, David Bates, Hani Jokhdar, et al. (+7)
496 [GO] 2020―Sep―21 Safety and efficacy of the Russian COVID-19 vaccine: more information needed Enrico Bucci, Konstantin Andreev, Anders Björkman, Raffaele Adolfo Calogero, Ernesto Carafoli, Piero Carninci, et al. (+10)
497 [GO] 2020―Sep―21 Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors’ reply Denis Y Logunov, Inna V Dolzhikova, Amir I Tukhvatullin, Dmitry V Shcheblyakov
498 [GO] 2020―Sep―21 What can we expect from first-generation COVID-19 vaccines? Malik Peiris, Gabriel M Leung
499 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Elia J Duh
500 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Frederick T Collison, Joseph Carroll
501 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Camilo Brandão-de-Resende, Alberto Diniz-Filho, Daniel V Vasconcelos-Santos
502 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Pingbo Ouyang, Xinyu Zhang, Yinghui Peng, Bing Jiang
503 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Pradeep Venkatesh
504 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 - Authors' reply Paula M Marinho, Heloisa Nascimento, Allexya A A Marcos, André C Romano, Rubens Belfort
505 [GO] 2020―Sep―17 Understanding Mexican health worker COVID-19 deaths David Agren
506 [GO] 2020―Sep―17 Brazil's COVID-19 response Maria Helena da Silva Bastos
507 [GO] 2020―Sep―17 Brazil's COVID-19 response Luiz Vicente Rizzo, Nelson Wolosker
508 [GO] 2020―Sep―17 Brazil's COVID-19 response Denis Souto Valente, Rafaela Koehler Zanella
509 [GO] 2020―Sep―17 Brazil's COVID-19 response Cecilia Siliansky de Andreazzi, Martha Lima Brandão, Marina Galvão Bueno, Gisele R Winck, Fabiana Lopes Rocha, Rafael L G Raimundo, et al. (+4)
510 [GO] 2020―Sep―17 Brazil's COVID-19 response Mauro R N Pontes, Julio Pereira Lima
511 [GO] 2020―Sep―17 COVID-19: a stress test for trust in science The Lancet
512 [GO] 2020―Sep―14 Catalysing the response to NCDI Poverty at a time of COVID-19 Karen Sliwa, Magdi Yacoub
513 [GO] 2020―Sep―14 Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly Jeffrey D Sachs, Salim Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Gabriela Cuevas Barron, et al. (+29)
514 [GO] 2020―Sep―07 Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access Alexandra L Phelan, Mark Eccleston-Turner, Michelle Rourke, Allan Maleche, Chenguang Wang
515 [GO] 2020―Sep―06 Azithromycin for severe COVID-19 Catherine E Oldenburg, Thuy Doan
516 [GO] 2020―Sep―06 Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial Remo H M Furtado, Otavio Berwanger, Henrique A Fonseca, Thiago D Corrêa, Leonardo R Ferraz, Maura G Lapa, et al. (+27)
517 [GO] 2020―Sep―04 Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia Denis Y Logunov, Inna V Dolzhikova, Olga V Zubkova, Amir I Tukhvatullin, Dmitry V Shcheblyakov, Alina S Dzharullaeva, et al. (+26)
518 [GO] 2020―Sep―04 COVID-19 vaccines: early success and remaining challenges Naor Bar-Zeev, Tom Inglesby
519 [GO] 2020―Sep―03 Is India missing COVID-19 deaths? Patralekha Chatterjee
520 [GO] 2020―Sep―03 COVID-19 exacerbates violence against health workers Sharmila Devi
521 [GO] 2020―Sep―03 Promotion of scientific research on COVID-19 in Turkey Fahrettin Koca
522 [GO] 2020―Sep―03 Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020 Gianfranco Alicandro, Giuseppe Remuzzi, Carlo La Vecchia
523 [GO] 2020―Sep―03 COVID-19: a new lens for non-communicable diseases The Lancet
524 [GO] 2020―Aug―29 Testing for responses to the wrong SARS-CoV-2 antigen? Carolina Rosadas, Paul Randell, Maryam Khan, Myra O McClure, Richard S Tedder
525 [GO] 2020―Aug―27 Research and higher education in the time of COVID-19 The Lancet
526 [GO] 2020―Aug―27 Health and medicine cannot solve COVID-19 Amy K McLennan, Anne Katrine Kleberg Hansen, Stanley J Ulijaszek
527 [GO] 2020―Aug―27 Surveillance is underestimating the burden of the COVID-19 pandemic Nisreen A Alwan
528 [GO] 2020―Aug―27 Bangladesh's COVID-19 testing criticised Sophie Cousins
529 [GO] 2020―Aug―27 COVID-19 vaccine trials should seek worthwhile efficacy Philip Krause, Thomas R Fleming, Ira Longini, Ana Maria Henao-Restrepo, Richard Peto, NE Dean, et al. (+14)
530 [GO] 2020―Aug―27 COVID-19 vaccines and neglected pregnancy Pradip Dashraath, Karin Nielsen-Saines, Shabir A Madhi, David Baud
531 [GO] 2020―Aug―20 COVID-19 and readjusting clinical trials Aaron van Dorn
532 [GO] 2020―Aug―20 Pandemics past and dystopian futures Margaret McCartney
533 [GO] 2020―Aug―18 Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study Barnaby E Young, Siew-Wai Fong, Yi-Hao Chan, Tze-Minn Mak, Li Wei Ang, Danielle E Anderson, et al. (+23)
534 [GO] 2020―Aug―17 SARS-CoV-2 renal tropism associates with acute kidney injury Fabian Braun, Marc Lütgehetmann, Susanne Pfefferle, Milagros N Wong, Alexander Carsten, Maja T Lindenmeyer, et al. (+12)
535 [GO] 2020―Aug―13 COVID-19 combination prevention requires attention to structural drivers Kent Buse, Alessandra Nilo, Jules Kim, Mark Heywood, Jeff Acaba
536 [GO] 2020―Aug―13 SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report Dagmar Jamiolkowski, Beda Mühleisen, Simon Müller, Alexander A Navarini, Alexandar Tzankov, Elisabeth Roider
537 [GO] 2020―Aug―13 Interference in scientific research on COVID-19 in Turkey Hasan Bayram, Nurdan Köktürk, Osman Elbek, Oğuz Kılınç, Abdullah Sayıner, Elif Dağlı
538 [GO] 2020―Aug―13 COVID-19 is an opportunity for reform in dentistry Richard G Watt
539 [GO] 2020―Aug―13 Donation and transplantation activity in the UK during the COVID-19 lockdown Alex R Manara, Lisa Mumford, Chris J Callaghan, Rommel Ravanan, Dale Gardiner
540 [GO] 2020―Aug―13 Sex differential in COVID-19 mortality varies markedly by age Sunil S Bhopal, Raj Bhopal
541 [GO] 2020―Aug―13 COVID-19's impact on Australia's health research workforce Anna Peeters, Greg Mullins, Denise Becker, Liliana Orellana, Patricia Livingston
542 [GO] 2020―Aug―13 COVID-19 trial co-enrolment and subsequent enrolment Elie Gertner
543 [GO] 2020―Aug―13 COVID-19 worsens Zimbabwe's health crisis Munyaradzi Makoni
544 [GO] 2020―Aug―13 Humanitarian crises in a global pandemic The Lancet
545 [GO] 2020―Aug―10 Patient-reported outcomes: central to the management of COVID-19 Olalekan Lee Aiyegbusi, Melanie J Calvert
546 [GO] 2020―Aug―06 Egyptian health workers arrested after COVID-19 comments Sharmila Devi
547 [GO] 2020―Aug―06 The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic Daisy Fancourt, Andrew Steptoe, Liam Wright
548 [GO] 2020―Aug―06 The need for an independent evaluation of the COVID-19 response in Spain Alberto García-Basteiro, Carlos Alvarez-Dardet, Alex Arenas, Rafael Bengoa, Carme Borrell, Margarita Del Val, et al. (+14)
549 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Evan J Keil
550 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Carina King, Lena Einhorn, Nele Brusselaers, Marcus Carlsson, Stefan Einhorn, Fredrik Elgh, et al. (+15)
551 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Johanna F Lindahl, Björn Olsen, Åke Lundkvist
552 [GO] 2020―Aug―06 COVID-19-a very visible pandemic David N Durrheim, Michael G Baker
553 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Andrew Ewing
554 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Raja Ramachandran
555 [GO] 2020―Aug―06 COVID-19-a very visible pandemic - Author's reply Johan Giesecke
556 [GO] 2020―Aug―06 Seroprevalence and presentation of SARS-CoV-2 in pregnancy Francesca Crovetto, Fàtima Crispi, Elisa Llurba, Francesc Figueras, María Dolores Gómez-Roig, Eduard Gratacós
557 [GO] 2020―Aug―03 COVID-19 spread in the UK: the end of the beginning? Roy M Anderson, T Déirdre Hollingsworth, Rebecca F Baggaley, Rosie Maddren, Carolin Vegvari
558 [GO] 2020―Jul―30 Political and institutional perils of Brazil's COVID-19 crisis Lorena G Barberia, Eduardo J Gómez
559 [GO] 2020―Jul―30 COVID-19 has “devastating” effect on women and girls Sophie Cousins
560 [GO] 2020―Jul―27 Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality Derek Headey, Rebecca Heidkamp, Saskia Osendarp, Marie Ruel, Nick Scott, Robert Black, et al. (+5)
561 [GO] 2020―Jul―27 Child malnutrition and COVID-19: the time to act is now Henrietta H Fore, Qu Dongyu, David M Beasley, Tedros A Ghebreyesus
562 [GO] 2020―Jul―23 Offline: Preparing for a vaccine against COVID-19 Richard Horton
563 [GO] 2020―Jul―23 COVID-19 and China: lessons and the way forward The Lancet
564 [GO] 2020―Jul―23 COVID-19 cases surge in Colombia Joe Parkin Daniels
565 [GO] 2020―Jul―23 Australia's First Nations' response to the COVID-19 pandemic Sandra Eades, Francine Eades, Daniel McCaullay, Lesley Nelson, Péta Phelan, Fiona Stanley
566 [GO] 2020―Jul―23 Dramatic interventions in the tragedy of the COVID-19 pandemic Cynda H Rushton, Bryan Doerries, Jeremy Greene, Gail Geller
567 [GO] 2020―Jul―23 COVID-19 vaccine affordability and accessibility Safura Abdool Karim
568 [GO] 2020―Jul―23 Pandemic science and politics Philip Ball
569 [GO] 2020―Jul―20 Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial Feng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, Jian-Ying Huang, Tao Jiang, Li-Hua Hou, et al. (+23)
570 [GO] 2020―Jul―20 Encouraging results from phase 1/2 COVID-19 vaccine trials Naor Bar-Zeev, William J Moss
571 [GO] 2020―Jul―20 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Pedro M Folegatti, Katie J Ewer, Parvinder K Aley, Brian Angus, Stephan Becker, Sandra Belij-Rammerstorfer, et al. (+353)
572 [GO] 2020―Jul―16 The Lancet-Chatham House Commission on improving population health post COVID-19 Harry Rutter, Richard Horton, Theresa M Marteau
573 [GO] 2020―Jul―16 Offline: COVID-19 and the dangers of Sinophobia Richard Horton
574 [GO] 2020―Jul―16 Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series Benjamin T Bradley, Heather Maioli, Robert Johnston, Irfan Chaudhry, Susan L Fink, Haodong Xu, et al. (+6)
575 [GO] 2020―Jul―16 Strengthening the global effort on COVID-19 research Alice Norton, Jeffrey Mphahlele, Yazdan Yazdanpanah, Peter Piot, Marta Tufet Bayona
576 [GO] 2020―Jul―16 France's COVID-19 response: balancing conflicting public health traditions Laëtitia Atlani-Duault, Franck Chauvin, Yazdan Yazdanpanah, Bruno Lina, Daniel Benamouzig, Lila Bouadma, et al. (+5)
577 [GO] 2020―Jul―16 COVID-19: Africa needs unprecedented attention to strengthen community health systems Lyudmila Nepomnyashchiy, Bernice Dahn, Rachel Saykpah, Mallika Raghavan
578 [GO] 2020―Jul―16 New funds proposed to prevent pandemics Ann Danaiya Usher
579 [GO] 2020―Jul―15 Assessing national performance in response to COVID-19 Dale Fisher, Yik Ying Teo, David Nabarro
580 [GO] 2020―Jul―14 COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Marion M Mafham, Enti Spata, Raphael Goldacre, Dominic Gair, Paula Curnow, Mark Bray, et al. (+14)
581 [GO] 2020―Jul―10 An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 Sheila Shaigany, Marlis Gnirke, Allison Guttmann, Hong Chong, Shane Meehan, Vanessa Raabe, et al. (+3)
582 [GO] 2020―Jul―10 Inflammatory olfactory neuropathy in two patients with COVID-19 Daniel Kirschenbaum, Lukas L Imbach, Silvia Ulrich, Elisabeth J Rushing, Emanuela Keller, Regina R Reimann, et al. (+7)
583 [GO] 2020―Jul―10 Community health workers reveal COVID-19 disaster in Brazil Gabriela Lotta, Clare Wenham, João Nunes, Denise Nacif Pimenta
584 [GO] 2020―Jul―09 Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19 Christian Funck-Brentano, Lee S Nguyen, Joe-Elie Salem
585 [GO] 2020―Jul―09 The Lancet COVID-19 Commission Jeffrey D Sachs, Richard Horton, Jessamy Bagenal, Yanis Ben Amor, Ozge Karadag Caman, Guillaume Lafortune
586 [GO] 2020―Jul―09 COVID-19: the worst may be yet to come The Lancet
587 [GO] 2020―Jul―09 Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers Catherine F Houlihan, Nina Vora, Thomas Byrne, Dan Lewer, Gavin Kelly, Judith Heaney, et al. (+333)
588 [GO] 2020―Jul―06 SARS-CoV-2 seroprevalence in COVID-19 hotspots Isabella Eckerle, Benjamin Meyer
589 [GO] 2020―Jul―06 Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Jesús Oteo, Miguel A Hernán, Mayte Pérez-Olmeda, et al. (+103)
590 [GO] 2020―Jul―03 Decisive leadership is a necessity in the COVID-19 response Ahmed Mohammed Obaid Al Saidi, Fowsiya Abikar Nur, Ahmed Salim Al-Mandhari, Maha El Rabbat, Assad Hafeez, Abdinasir Abubakar
591 [GO] 2020―Jul―02 After COVID-19, a future for the world's children? Helen Clark, Awa Marie Coll-Seck, Anshu Banerjee, Stefan Peterson, Sarah L Dalglish, Shanthi Ameratunga, et al. (+35)
592 [GO] 2020―Jul―02 Early lessons from a second COVID-19 lockdown in Leicester, UK Joshua Nazareth, Jatinder S Minhas, David R Jenkins, Amandip Sahota, Kamlesh Khunti, Pranab Haldar, Manish Pareek
593 [GO] 2020―Jul―02 The Wakley-Wu Lien Teh Prize Essay 2020: Chinese health workers' experiences during the COVID-19 pandemic Helena Hui Wang, Esther Lau, Richard Horton
594 [GO] 2020―Jul―02 Financial crisis at PAHO in the time of COVID-19: a call for action Arlene King, Jon Kim Andrus, J Peter Figueroa
595 [GO] 2020―Jul―02 Offline: It's time to convene nations to end this pandemic Richard Horton
596 [GO] 2020―Jun―26 The harms of police frisking in times of a pandemic Ghaith Aljayyoussi
597 [GO] 2020―Jun―25 Generation coronavirus? The Lancet
598 [GO] 2020―Jun―25 Myocarditis in a 16-year-old boy positive for SARS-CoV-2 Massimiliano Gnecchi, Francesco Moretti, Emilio Maria Bassi, Sergio Leonardi, Rossana Totaro, Luciano Perotti, et al. (+6)
599 [GO] 2020―Jun―19 Reordering gender systems: can COVID-19 lead to improved gender equality and health? Tania King, Belinda Hewitt, Bradley Crammond, Georgina Sutherland, Humaira Maheen, Anne Kavanagh
600 [GO] 2020―Jun―19 Ethnic disparities in COVID-19 mortality: are comorbidities to blame? Krithi Ravi
601 [GO] 2020―Jun―19 Solidarity in the wake of COVID-19: reimagining the International Health Regulations Allyn L Taylor, Roojin Habibi, Gian Luca Burci, Stephanie Dagron, Mark Eccleston-Turner, Lawrence O Gostin, et al. (+9)
602 [GO] 2020―Jun―18 Challenges for the female academic during the COVID-19 pandemic Brooke Peterson Gabster, Kim van Daalen, Roopa Dhatt, Michele Barry
603 [GO] 2020―Jun―18 Men's health: COVID-19 pandemic highlights need for overdue policy action Peter Baker, Alan White, Rosemary Morgan
604 [GO] 2020―Jun―18 COVID-19 resurgence in Iran Sharmila Devi
605 [GO] 2020―Jun―18 Seeing COVID-19 through José Saramago's Blindness Daniel Marchalik, Dmitriy Petrov
606 [GO] 2020―Jun―18 Global governance for COVID-19 vaccines The Lancet
607 [GO] 2020―Jun―18 Offline: A novel solution to live with coronavirus Richard Horton
608 [GO] 2020―Jun―18 Wakley Prize Essay 2020: medicine and plain truths in a pandemic year Niall Boyce, Bianca Brandon, Gabriella Merry, Joanna Palmer, Jonathan Pimm, Maneet Virdi
609 [GO] 2020―Jun―16 Overcoming fragmentation of health research in Europe: lessons from COVID-19 Karin R Sipido, Fernando Antoñanzas, Julio Celis, Laurent Degos, Richard Frackowiak, Valentin Fuster, et al. (+14)
610 [GO] 2020―Jun―12 COVID-19 and ethnicity: who will research results apply to? Shaun Treweek, Nita G Forouhi, K M Venkat Narayan, Kamlesh Khunti
611 [GO] 2020―Jun―12 COVID-19, nuclear war, and global warming: lessons for our vulnerable world James E Muller, David G Nathan
612 [GO] 2020―Jun―12 Gendered effects of school closures during the COVID-19 pandemic Katarzyna Burzynska, Gabriela Contreras
613 [GO] 2020―Jun―11 Have deaths from COVID-19 in Europe plateaued due to herd immunity? Lucy C Okell, Robert Verity, Oliver J Watson, Swapnil Mishra, Patrick Walker, Charlie Whittaker, et al. (+8)
614 [GO] 2020―Jun―11 COVID-19 vaccines for all? Ann Danaiya Usher
615 [GO] 2020―Jun―11 Offline: COVID-19-what we can expect to come Richard Horton
616 [GO] 2020―Jun―06 Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Mandeep R Mehra, Frank Ruschitzka, Amit N Patel
617 [GO] 2020―Jun―04 Offline: COVID-19 and the ethics of memory Richard Horton
618 [GO] 2020―Jun―04 Salient lessons from Russia's COVID-19 outbreak The Lancet
619 [GO] 2020―Jun―04 Early evidence of pronounced brain involvement in fatal COVID-19 outcomes Claus Hann von Weyhern, Ines Kaufmann, Frauke Neff, Marcus Kremer
620 [GO] 2020―Jun―04 Active case finding with case management: the key to tackling the COVID-19 pandemic Zhongjie Li, Qiulan Chen, Luzhao Feng, Lance Rodewald, Yinyin Xia, Hailiang Yu, et al. (+53)
621 [GO] 2020―Jun―04 Indigenous populations: left behind in the COVID-19 response Kaitlin Curtice, Esther Choo
622 [GO] 2020―Jun―04 Quantifying additional COVID-19 symptoms will save lives Cristina Menni, Carole H Sudre, Claire J Steves, Sebastien Ourselin, Tim D Spector
623 [GO] 2020―Jun―04 COVID-19 vaccine development pipeline gears up Asher Mullard
624 [GO] 2020―Jun―03 Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis The Lancet Editors
625 [GO] 2020―Jun―01 Physical distancing, face masks, and eye protection for prevention of COVID-19 C Raina MacIntyre, Quanyi Wang
626 [GO] 2020―Jun―01 Informal home care providers: the forgotten health-care workers during the COVID-19 pandemic Emily Ying Yang Chan, Nina Gobat, Jean H Kim, Elizabeth A Newnham, Zhe Huang, Heidi Hung, et al. (+4)
627 [GO] 2020―Jun―01 Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis Derek K Chu, Elie A Akl, Stephanie Duda, Karla Solo, Sally Yaacoub, Holger J Schünemann, et al. (+40)
628 [GO] 2020―May―29 The right to health must guide responses to COVID-19 Dainius Pūras, Judith Bueno de Mesquita, Luisa Cabal, Allan Maleche, Benjamin Mason Meier
629 [GO] 2020―May―29 Mitigating the risks of surgery during the COVID-19 pandemic Paul S Myles, Salome Maswime
630 [GO] 2020―May―29 Cancer and COVID-19: what do we really know? Philip M Poortmans, Valentina Guarneri, Maria-João Cardoso
631 [GO] 2020―May―29 Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Dmitri Nepogodiev, James C Glasbey, Elizabeth Li, Omar M Omar, Joana FF Simoes, Tom EF Abbott, et al. (+1203)
632 [GO] 2020―May―28 COVID-19 in Africa: no room for complacency The Lancet
633 [GO] 2020―May―28 COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study Lennard Y W Lee, Jean Baptiste Cazier, T Starkey, C D Turnbull, Rachel Kerr, Gary Middleton
634 [GO] 2020―May―28 Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, Yu Shyr, Samuel M Rubinstein, Donna R Rivera, et al. (+230)
635 [GO] 2020―May―28 Fears of “highly catastrophic” COVID-19 spread in Yemen Sharmila Devi
636 [GO] 2020―May―28 COVID-19 strains remote regions of Peru Barbara Fraser
637 [GO] 2020―May―28 The starting line for COVID-19 vaccine development Nelson Lee, Allison McGeer
638 [GO] 2020―May―28 Offline: After COVID-19-is an “alternate society” possible? Richard Horton
639 [GO] 2020―May―27 A view from UK public health registrars on the challenges of COVID-19 Matilda Allen, Isobel Braithwaite, Shelui Collinson, Youssof Oskrochi, Anamika Basu
640 [GO] 2020―May―27 The COVID-19 MS Coalition-accelerating diagnostics, prognostics, and treatment Weston Struwe, Edward Emmott, Melanie Bailey, Michal Sharon, Andrea Sinz, Fernando J Corrales, et al. (+4)
641 [GO] 2020―May―27 Excess mortality in men and women in Massachusetts during the COVID-19 pandemic Nancy Krieger, Jarvis T Chen, Pamela D Waterman
642 [GO] 2020―May―27 COVID-19 testing delays and pathology services in the UK Jangu Banatvala
643 [GO] 2020―May―25 Assistance Publique-Hôpitaux de Paris' response to the COVID-19 pandemic
644 [GO] 2020―May―25 Caution against corticosteroid-based COVID-19 treatment Chong Tang, Yichuan Wang, Houshan Lv, Zhenpeng Guan, Jin Gu
645 [GO] 2020―May―25 COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? Cheryl L Maier, Alexander D Truong, Sara C Auld, Derek M Polly, Christin-Lauren Tanksley, Alexander Duncan
646 [GO] 2020―May―25 Revisiting the 1957 and 1968 influenza pandemics Mark Honigsbaum
647 [GO] 2020―May―22 Compassion in a time of COVID-19 Sandro Galea
648 [GO] 2020―May―22 Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, Li-Hua Hou, Wen-Juan Wang, Jing-Xin Li, et al. (+15)
649 [GO] 2020―May―22 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Mandeep R Mehra, Sapan S Desai, Frank Ruschitzka, Amit N Patel
650 [GO] 2020―May―22 Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? Christian Funck-Brentano, Joe-Elie Salem
651 [GO] 2020―May―21 Offline: Health in the unhappy time of COVID-19 Richard Horton
652 [GO] 2020―May―21 The plight of essential workers during the COVID-19 pandemic The Lancet
653 [GO] 2020―May―21 Detection of SARS-CoV-2 in human breastmilk Rüdiger Groß, Carina Conzelmann, Janis A Müller, Steffen Stenger, Karin Steinhart, Frank Kirchhoff, Jan Münch
654 [GO] 2020―May―20 Attacks against health-care personnel must stop, especially as the world fights COVID-19 Donna McKay, Michele Heisler, Ranit Mishori, Howard Catton, Otmar Kloiber
655 [GO] 2020―May―20 Critically ill patients with COVID-19 in New York City Giacomo Grasselli, Alberto Zanella
656 [GO] 2020―May―20 Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study Matthew J Cummings, Matthew R Baldwin, Darryl Abrams, Samuel D Jacobson, Benjamin J Meyer, Elizabeth M Balough, et al. (+9)
657 [GO] 2020―May―20 Electron microscopy of SARS-CoV-2: a challenging task Cynthia S Goldsmith, Sara E Miller, Roosecelis B Martines, Hannah A Bullock, Sherif R Zaki
658 [GO] 2020―May―20 Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply Zsuzsanna Varga, Andreas J Flammer, Peter Steiger, Martina Haberecker, Rea Andermatt, Annelies Zinkernagel, et al. (+5)
659 [GO] 2020―May―16 Voluntary collective isolation as a best response to COVID-19 for indigenous populations? A case study and protocol from the Bolivian Amazon Hillard S Kaplan, Benjamin C Trumble, Jonathan Stieglitz, Roberta Mendez Mamany, Maguin Gutierrez Cayuba, Leonardina Maito Moye, et al. (+9)
660 [GO] 2020―May―16 Steam inhalation and paediatric burns during the COVID-19 pandemic Colin T Brewster, Jia Choong, Clare Thomas, David Wilson, Naiem Moiemen
661 [GO] 2020―May―16 Sex workers must not be forgotten in the COVID-19 response Lucy Platt, Jocelyn Elmes, Luca Stevenson, Victoria Holt, Stephen Rolles, Rachel Stuart
662 [GO] 2020―May―16 Use of herbal drugs to treat COVID-19 should be with caution Yichang Yang
663 [GO] 2020―May―15 Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19 Bryan Williams, Yi Zhang
664 [GO] 2020―May―15 Offline: Don't let COVID-19 divert us completely Richard Horton
665 [GO] 2020―May―15 Emergency ambulance services for heart attack and stroke during UK's COVID-19 lockdown Jenny Lumley Holmes, Simon Brake, Mark Docherty, Richard Lilford, Sam Watson
666 [GO] 2020―May―15 Personal protective equipment needs in the USA during the COVID-19 pandemic Suhas Gondi, Adam L Beckman, Nicholas Deveau, Ali S Raja, Megan L Ranney, Rachel Popkin, Shuhan He
667 [GO] 2020―May―15 Health inequity during the COVID-19 pandemic: a cry for ethical global leadership David Chiriboga, Juan Garay, Paulo Buss, Rocío Sáenz Madrigal, Laetitia Charmaine Rispel
668 [GO] 2020―May―15 Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study Francisco J de Abajo, Sara Rodríguez-Martín, Victoria Lerma, Gina Mejía-Abril, Mónica Aguilar, Amelia García-Luque, et al. (+25)
669 [GO] 2020―May―15 Global coordination on cross-border travel and trade measures crucial to COVID-19 response Kelley Lee, Catherine Z Worsnop, Karen A Grépin, Adam Kamradt-Scott
670 [GO] 2020―May―13 Kawasaki-like disease: emerging complication during the COVID-19 pandemic Russell M Viner, Elizabeth Whittaker
671 [GO] 2020―May―13 Where are the ECDC and the EU-wide responses in the COVID-19 pandemic? Jacint Jordana, Juan Carlos Triviño-Salazar
672 [GO] 2020―May―13 Consider pregnancy in COVID-19 therapeutic drug and vaccine trials Clare L Whitehead, Susan P Walker
673 [GO] 2020―May―13 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Lucio Verdoni, Angelo Mazza, Annalisa Gervasoni, Laura Martelli, Maurizio Ruggeri, Matteo Ciuffreda, et al. (+2)
674 [GO] 2020―May―12 Africa faces difficult choices in responding to COVID-19 Titus Divala, Rachael M Burke, Latif Ndeketa, Elizabeth L Corbett, Peter MacPherson
675 [GO] 2020―May―12 Retinal findings in patients with COVID-19 Paula M Marinho, Allexya A A Marcos, André C Romano, Heloisa Nascimento, Rubens Belfort
676 [GO] 2020―May―12 Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study Amitava Banerjee, Laura Pasea, Steve Harris, Arturo Gonzalez-Izquierdo, Ana Torralbo, Laura Shallcross, et al. (+10)
677 [GO] 2020―May―11 Organ procurement and transplantation during the COVID-19 pandemic Alexandre Loupy, Olivier Aubert, Peter P Reese, Olivier Bastien, Florian Bayer, Christian Jacquelinet
678 [GO] 2020―May―10 Interferon beta-1b for COVID-19 Sarah Shalhoub
679 [GO] 2020―May―10 Sharpening the global focus on ethnicity and race in the time of COVID-19 Neeraj Bhala, Gwenetta Curry, Adrian R Martineau, Charles Agyemang, Raj Bhopal
680 [GO] 2020―May―10 Prevention and control of non-communicable diseases in the COVID-19 response Hans Henri P Kluge, Kremlin Wickramasinghe, Holly L Rippin, Romeu Mendes, David H Peters, Anna Kontsevaya, Joao Breda
681 [GO] 2020―May―10 Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai-Hin Chung, Man-Yee Chu, et al. (+38)
682 [GO] 2020―May―08 COVID-19: PCR screening of asymptomatic health-care workers at London hospital Thomas A Treibel, Charlotte Manisty, Maudrian Burton, Áine McKnight, Jonathan Lambourne, João B Augusto, et al. (+4)
683 [GO] 2020―May―07 New Zealand eliminates COVID-19 Sophie Cousins
684 [GO] 2020―May―07 Chile plans controversial COVID-19 certificates Barbara Fraser
685 [GO] 2020―May―07 COVID-19 in Brazil: “So what?” The Lancet
686 [GO] 2020―May―07 Calling for a COVID-19 One Health Research Coalition John H Amuasi, Christian Walzer, David Heymann, Hélène Carabin, Le Thi Huong, Andrew Haines, Andrea S Winkler
687 [GO] 2020―May―07 Hyperinflammatory shock in children during COVID-19 pandemic Shelley Riphagen, Xabier Gomez, Carmen Gonzalez-Martinez, Nick Wilkinson, Paraskevi Theocharis
688 [GO] 2020―May―07 Offline: Independent science advice for COVID-19-at last Richard Horton
689 [GO] 2020―May―06 COVID-19-associated nephritis: early warning for disease severity and complications? Oliver Gross, Onnen Moerer, Manfred Weber, Tobias B Huber, Simone Scheithauer
690 [GO] 2020―May―05 Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 Paolo Perini, Bilal Nabulsi, Claudio Bianchini Massoni, Matteo Azzarone, Antonio Freyrie
691 [GO] 2020―May―05 Has COVID-19 subverted global health? Richard Cash, Vikram Patel
692 [GO] 2020―May―05 Is the HScore useful in COVID-19? David L Leverenz, Teresa K Tarrant
693 [GO] 2020―May―05 SARS-CoV-2 and influenza virus co-infection Elena Cuadrado-Payán, Enrique Montagud-Marrahi, Manuel Torres-Elorza, Marta Bodro, Miquel Blasco, Esteban Poch, et al. (+2)
694 [GO] 2020―May―05 The invisible pandemic Johan Giesecke
695 [GO] 2020―May―04 Obesity could shift severe COVID-19 disease to younger ages David A Kass, Priya Duggal, Oscar Cingolani
696 [GO] 2020―May―04 COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges Alexandra L Phelan
697 [GO] 2020―May―04 The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises David Nott
698 [GO] 2020―May―04 The arrival of SARS-CoV-2 in Venezuela Alberto E Paniz-Mondolfi, Emilia M Sordillo, Marilianna C Márquez-Colmenarez, Lourdes A Delgado-Noguera, Alfonso J Rodriguez-Morales
699 [GO] 2020―May―04 Community participation is crucial in a pandemic Cicely Marston, Alicia Renedo, Sam Miles
700 [GO] 2020―Apr―30 Prisons are “in no way equipped” to deal with COVID-19 Talha Burki
701 [GO] 2020―Apr―30 Considering BCG vaccination to reduce the impact of COVID-19 Nigel Curtis, Annie Sparrow, Tedros A Ghebreyesus, Mihai G Netea
702 [GO] 2020―Apr―30 A COVID-19 conference at AIDS 2020: Virtual Anton Pozniak, Linda-Gail Bekker, Adeeba Kamarulzaman, Monica Gandhi, Richard Horton, Pamela Das, Chris Beyrer
703 [GO] 2020―Apr―30 COVID-19: remaking the social contract The Lancet
704 [GO] 2020―Apr―29 Preventing major outbreaks of COVID-19 in jails Justin T Okano, Sally Blower
705 [GO] 2020―Apr―29 Institutional, not home-based, isolation could contain the COVID-19 outbreak Borame L Dickens, Joel R Koo, Annelies Wilder-Smith, Alex R Cook
706 [GO] 2020―Apr―29 Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, et al. (+40)
707 [GO] 2020―Apr―29 Remdesivir for COVID-19: challenges of underpowered studies John David Norrie
708 [GO] 2020―Apr―27 Atypical presentation of COVID-19 in young infants Nadia Nathan, Blandine Prevost, Harriet Corvol
709 [GO] 2020―Apr―27 What policy makers need to know about COVID-19 protective immunity Daniel M Altmann, Daniel C Douek, Rosemary J Boyton
710 [GO] 2020―Apr―27 What does it mean to be made vulnerable in the era of COVID-19? Ayesha Ahmad, Ryoa Chung, Lisa Eckenwiler, Agomani Mitra Ganguli, Matthew Hunt, Rebecca Richards, et al. (+4)
711 [GO] 2020―Apr―23 COVID-19 fault lines Esther K Choo
712 [GO] 2020―Apr―23 India under COVID-19 lockdown The Lancet
713 [GO] 2020―Apr―23 Medical students for health-care staff shortages during the COVID-19 pandemic Sten Rasmussen, Phillip Sperling, Mathias Såby Poulsen, Jeppe Emmersen, Stig Andersen
714 [GO] 2020―Apr―23 Travel restrictions hampering COVID-19 response Sharmila Devi
715 [GO] 2020―Apr―23 Global call to action for inclusion of migrants and refugees in the COVID-19 response Miriam Orcutt, Parth Patel, Rachel Burns, Lucinda Hiam, Rob Aldridge, Delan Devakumar, et al. (+3)
716 [GO] 2020―Apr―23 Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes Denis Doyen, Pamela Moceri, Dorothée Ducreux, Jean Dellamonica
717 [GO] 2020―Apr―22 Neurosurgery in an infant with COVID-19 Giorgio Carrabba, Leonardo Tariciotti, Sophie Guez, Edoardo Calderini, Marco Locatelli
718 [GO] 2020―Apr―22 First experience of COVID-19 screening of health-care workers in England Ewan Hunter, David A Price, Elizabeth Murphy, Ina Schim van der Loeff, Kenneth F Baker, Dennis Lendrem, et al. (+6)
719 [GO] 2020―Apr―22 The key role of palliative care in response to the COVID-19 tsunami of suffering Lukas Radbruch, Felicia Marie Knaul, Liliana de Lima, Cornelis de Joncheere, Afsan Bhadelia
720 [GO] 2020―Apr―22 COVID-19: a need for real-time monitoring of weekly excess deaths David A Leon, Vladimir M Shkolnikov, Liam Smeeth, Per Magnus, Markéta Pechholdová, Christopher I Jarvis
721 [GO] 2020―Apr―21 Endothelial cell infection and endotheliitis in COVID-19 Zsuzsanna Varga, Andreas J Flammer, Peter Steiger, Martina Haberecker, Rea Andermatt, Annelies S Zinkernagel, et al. (+4)
722 [GO] 2020―Apr―21 Hospital-based use of thromboprophylaxis in patients with COVID-19 Alex C Spyropoulos, Walter Ageno, Elliot S Barnathan
723 [GO] 2020―Apr―21 Universal weekly testing as the UK COVID-19 lockdown exit strategy Julian Peto, Nisreen A Alwan, Keith M Godfrey, Rochelle A Burgess, David J Hunter, Elio Riboli, et al. (+28)
724 [GO] 2020―Apr―21 Ethnicity and COVID-19: an urgent public health research priority Manish Pareek, Mansoor N Bangash, Nilesh Pareek, Daniel Pan, Shirley Sze, Jatinder S Minhas, et al. (+2)
725 [GO] 2020―Apr―17 SARS-CoV-2 and viral sepsis: observations and hypotheses Hui Li, Liang Liu, Dingyu Zhang, Jiuyang Xu, Huaping Dai, Nan Tang, et al. (+2)
726 [GO] 2020―Apr―16 Flooded by the torrent: the COVID-19 drug pipeline Asher Mullard
727 [GO] 2020―Apr―16 COVID-19 exacerbating inequalities in the US Aaron van Dorn, Rebecca E Cooney, Miriam L Sabin
728 [GO] 2020―Apr―16 Sustaining containment of COVID-19 in China The Lancet
729 [GO] 2020―Apr―16 COVID-19 in the USA: a question of time The Lancet
730 [GO] 2020―Apr―16 Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity Kar Keung Cheng, Tai Hing Lam, Chi Chiu Leung
731 [GO] 2020―Apr―16 Sarah Gilbert: carving a path towards a COVID-19 vaccine Richard Lane
732 [GO] 2020―Apr―16 COVID-19: the case for health-care worker screening to prevent hospital transmission James R M Black, Chris Bailey, Joanna Przewrocka, Krijn K Dijkstra, Charles Swanton
733 [GO] 2020―Apr―15 SARS-CoV-2 shedding and infectivity Barry Atkinson, Eskild Petersen
734 [GO] 2020―Apr―15 SARS-CoV-2 shedding and infectivity - Authors' reply Fei Zhou, Guohui Fan, Zhibo Liu, Bin Cao
735 [GO] 2020―Apr―09 The gendered dimensions of COVID-19 The Lancet
736 [GO] 2020―Apr―09 Regulators split on antimalarials for COVID-19 Susan Jaffe
737 [GO] 2020―Apr―09 Virtual health care in the era of COVID-19 Paul Webster
738 [GO] 2020―Apr―09 Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed Marc Feldmann, Ravinder N Maini, James N Woody, Stephen T Holgate, Gregory Winter, Matthew Rowland, et al. (+2)
739 [GO] 2020―Apr―09 Palliative care and the COVID-19 pandemic The Lancet
740 [GO] 2020―Apr―09 Centring sexual and reproductive health and justice in the global COVID-19 response Kelli Stidham Hall, Goleen Samari, Samantha Garbers, Sara E Casey, Dazon Dixon Diallo, Miriam Orcutt, et al. (+3)
741 [GO] 2020―Apr―09 Offline: COVID-19-bewilderment and candour Richard Horton
742 [GO] 2020―Apr―08 Beware of the second wave of COVID-19 Shunqing Xu, Yuanyuan Li
743 [GO] 2020―Apr―08 Localising an asset-based COVID-19 response in Ecuador Irene Torres, Fernando Sacoto
744 [GO] 2020―Apr―08 First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment Kathy Leung, Joseph T Wu, Di Liu, Gabriel M Leung
745 [GO] 2020―Apr―04 Urgent dental care for patients during the COVID-19 pandemic Manas Dave, Noha Seoudi, Paul Coulthard
746 [GO] 2020―Apr―02 Monitoring behavioural insights related to COVID-19 Cornelia Betsch, Lothar H Wieler, Katrine Habersaat
747 [GO] 2020―Apr―02 Redefining vulnerability in the era of COVID-19 The Lancet
748 [GO] 2020―Apr―02 Global coalition to accelerate COVID-19 clinical research in resource-limited settings
749 [GO] 2020―Apr―02 The COVID-19 pandemic in the USA: what might we expect? Gerardo Chowell, Kenji Mizumoto
750 [GO] 2020―Apr―02 Medical student involvement in the COVID-19 response Daniel M Baker, Sanchita Bhatia, Samuel Brown, William Cambridge, Sivesh K Kamarajah, Kenneth A McLean, et al. (+5)
751 [GO] 2020―Apr―02 COVID-19 will not leave behind refugees and migrants The Lancet
752 [GO] 2020―Apr―02 Offline: COVID-19-what countries must do now Richard Horton
753 [GO] 2020―Apr―02 A planetary health perspective on COVID-19: a call for papers Alastair Brown, Richard Horton
754 [GO] 2020―Apr―02 Developing antibody tests for SARS-CoV-2 Anna Petherick
755 [GO] 2020―Apr―01 Essential care of critical illness must not be forgotten in the COVID-19 pandemic Tim Baker, Carl Otto Schell, Dan Brun Petersen, Hendry Sawe, Karima Khalid, Samson Mndolo, et al. (+6)
756 [GO] 2020―Apr―01 Racism and discrimination in COVID-19 responses Delan Devakumar, Geordan Shannon, Sunil S Bhopal, Ibrahim Abubakar
757 [GO] 2020―Mar―31 Medicine: before COVID-19, and after Margaret McCartney
758 [GO] 2020―Mar―31 Refugee and migrant health in the COVID-19 response Hans Henri P Kluge, Zsuzsanna Jakab, Jozef Bartovic, Veronika D'Anna, Santino Severoni
759 [GO] 2020―Mar―31 Ensuring global access to COVID-19 vaccines Gavin Yamey, Marco Schäferhoff, Richard Hatchett, Muhammad Pate, Feng Zhao, Kaci Kennedy McDade
760 [GO] 2020―Mar―30 Dementia care during COVID-19 Huali Wang, Tao Li, Paola Barbarino, Serge Gauthier, Henry Brodaty, José Luis Molinuevo, et al. (+6)
761 [GO] 2020―Mar―27 Tracking COVID-19 responsibly Rania Muhareb, Rita Giacaman
762 [GO] 2020―Mar―27 A role for CT in COVID-19? What data really tell us so far Michael D Hope, Constantine A Raptis, Amar Shah, Mark M Hammer, Travis S Henry
763 [GO] 2020―Mar―27 Structural violence in the era of a new pandemic: the case of the Gaza Strip David Mills, Bram Wispelwey, Rania Muhareb, Mads Gilbert
764 [GO] 2020―Mar―26 A citizen's thoughts about COVID-19 Ronald Chow
765 [GO] 2020―Mar―26 Venezuelan migrants “struggling to survive” amid COVID-19 Joe Parkin Daniels
766 [GO] 2020―Mar―26 Offline: COVID-19 and the NHS-“a national scandal” Richard Horton
767 [GO] 2020―Mar―26 COVID-19 cacophony: is there any orchestra conductor? Antoine Flahault
768 [GO] 2020―Mar―26 COVID-19 gives the lie to global health expertise Sarah L Dalglish
769 [GO] 2020―Mar―26 WHO launches crowdfund for COVID-19 response Ann Danaiya Usher
770 [GO] 2020―Mar―26 COVID-19: learning from experience The Lancet
771 [GO] 2020―Mar―25 Parenting in a time of COVID-19 Lucie Cluver, Jamie M Lachman, Lorraine Sherr, Inge Wessels, Etienne Krug, Sabine Rakotomalala, et al. (+9)
772 [GO] 2020―Mar―24 COVID-19 in Europe: the Italian lesson Andrea Saglietto, Fabrizio D’Ascenzo, Giuseppe Biondi Zoccai, Gaetano Maria De Ferrari
773 [GO] 2020―Mar―24 National UK programme of community health workers for COVID-19 response Andy Haines, Enrique Falceto de Barros, Anita Berlin, David L Heymann, Matthew J Harris
774 [GO] 2020―Mar―24 Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? Andrew I Ritchie, Aran Singanayagam
775 [GO] 2020―Mar―20 Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma Brian McCloskey, Alimuddin Zumla, Giuseppe Ippolito, Lucille Blumberg, Paul Arbon, Anita Cicero, et al. (+3)
776 [GO] 2020―Mar―19 The global community needs to swiftly ramp up the response to contain COVID-19 Dale Fisher, Annelies Wilder-Smith
777 [GO] 2020―Mar―19 Offline: COVID-19-a reckoning Richard Horton
778 [GO] 2020―Mar―19 Canada and COVID-19: learning from SARS Paul Webster
779 [GO] 2020―Mar―19 COVID-19: protecting health-care workers The Lancet
780 [GO] 2020―Mar―18 COVID-19 battle during the toughest sanctions against Iran Amirhossein Takian, Azam Raoofi, Sara Kazempour-Ardebili
781 [GO] 2020―Mar―18 COVID-19 cacophony: is there any orchestra conductor? Antoine Flahault
782 [GO] 2020―Mar―18 Will COVID-19 generate global preparedness? Kathryn H Jacobsen
783 [GO] 2020―Mar―18 Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries Nirmal Kandel, Stella Chungong, Abbas Omaar, Jun Xing
784 [GO] 2020―Mar―17 Clinical course and mortality risk of severe COVID-19 Paul Weiss, David R Murdoch
785 [GO] 2020―Mar―17 Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures Rachael Pung, Calvin J Chiew, Barnaby E Young, Sarah Chin, Mark I-C Chen, Hannah E Clapham, et al. (+62)
786 [GO] 2020―Mar―17 Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic Jigang Wang, Chengchao Xu, Yin Kwan Wong, Yingke He, Ayôla A Adegnika, Peter G Kremsner, et al. (+8)
787 [GO] 2020―Mar―17 Evidence informing the UK's COVID-19 public health response must be transparent Nisreen A Alwan, Raj Bhopal, Rochelle A Burgess, Tim Colburn, Luis E Cuevas, George Davey Smith, et al. (+23)
788 [GO] 2020―Mar―17 COVID-19: towards controlling of a pandemic Juliet Bedford, Delia Enria, Johan Giesecke, David L Heymann, Chikwe Ihekweazu, Gary Kobinger, et al. (+7)
789 [GO] 2020―Mar―16 COVID-19: consider cytokine storm syndromes and immunosuppression Puja Mehta, Daniel F McAuley, Michael Brown, Emilie Sanchez, Rachel S Tattersall, Jessica J Manson
790 [GO] 2020―Mar―13 Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term? Manfred S Green
791 [GO] 2020―Mar―13 COVID-19 and Italy: what next? Andrea Remuzzi, Giuseppe Remuzzi
792 [GO] 2020―Mar―13 First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA Isaac Ghinai, Tristan D McPherson, Jennifer C Hunter, Hannah L Kirking, Demian Christiansen, Kiran Joshi, et al. (+32)
793 [GO] 2020―Mar―12 COVID-19: the medium is the message Laurie Garrett
794 [GO] 2020―Mar―11 Comorbidities and multi-organ injuries in the treatment of COVID-19 Tianbing Wang, Zhe Du, Fengxue Zhu, Zhaolong Cao, Youzhong An, Yan Gao, Baoguo Jiang
795 [GO] 2020―Mar―11 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, et al. (+13)
796 [GO] 2020―Mar―09 How will country-based mitigation measures influence the course of the COVID-19 epidemic? Roy M Anderson, Hans Heesterbeek, Don Klinkenberg, T Déirdre Hollingsworth
797 [GO] 2020―Mar―09 Middle East respiratory syndrome Ziad A Memish, Stanley Perlman, Maria D Van Kerkhove, Alimuddin Zumla
798 [GO] 2020―Mar―06 Are high-performing health systems resilient against the COVID-19 epidemic? Helena Legido-Quigley, Nima Asgari, Yik Ying Teo, Gabriel M Leung, Hitoshi Oshitani, Keiji Fukuda, et al. (+4)
799 [GO] 2020―Mar―06 COVID-19: the gendered impacts of the outbreak Clare Wenham, Julia Smith, Rosemary Morgan
800 [GO] 2020―Mar―06 SARS-CoV-2 is an appropriate name for the new coronavirus Yuntao Wu, Wenzhe Ho, Yaowei Huang, Dong-Yan Jin, Shiyue Li, Shan-Lu Liu, et al. (+6)
801 [GO] 2020―Mar―05 COVID-19: too little, too late? The Lancet
802 [GO] 2020―Mar―04 Mitigate the effects of home confinement on children during the COVID-19 outbreak Guanghai Wang, Yunting Zhang, Jin Zhao, Jun Zhang, Fan Jiang
803 [GO] 2020―Mar―04 Has China faced only a herald wave of